data_1yiu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yiu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.781 HD23 ' HG3' ' A' ' 12' ' ' LYS . 4.2 mm? . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 120.79 0.329 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.437 ' HG2' ' CD1' ' A' ' 10' ' ' TRP . 5.9 Cg_exo -53.49 142.22 59.83 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.916 2.411 . . . . 0.0 110.809 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -40.91 97.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.041 3.161 . . . . 0.0 114.261 -172.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.61 -27.34 4.97 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.345 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.595 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 95.7 m95 -85.55 163.49 18.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.472 0.177 . . . . 0.0 111.447 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.579 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 10.1 tp10 -163.61 152.18 13.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.096 173.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.781 ' HG3' HD23 ' A' ' 6' ' ' LEU . 30.0 mtmt -91.79 100.92 13.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.355 0.598 . . . . 0.0 109.594 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -111.22 163.68 13.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.146 -173.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.3 p -114.39 147.73 38.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.124 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -94.94 -169.38 1.99 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.622 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.4 p -71.31 -24.87 62.21 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.409 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.91 -25.8 14.88 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.045 -171.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.42 14.79 2.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.054 -1.069 . . . . 0.0 113.003 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -87.28 153.73 21.25 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.862 -0.199 . . . . 0.0 110.483 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.8 m -104.22 121.98 56.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.19 0.519 . . . . 0.0 110.169 174.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.451 ' CD1' HG21 ' A' ' 30' ' ' THR . 43.2 p90 -124.69 171.64 9.91 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.806 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 80.2 m-85 -117.23 118.16 31.55 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.779 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 9.8 p -96.83 131.73 42.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.652 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -101.1 115.86 31.47 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -66.95 -32.73 74.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.82 -178.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -66.46 -61.2 2.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.652 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.55 ' HB ' HG12 ' A' ' 29' ' ' ILE . 11.2 p -87.28 -13.87 42.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.767 -176.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 66.13 33.29 7.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.423 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.55 HG12 ' HB ' ' A' ' 27' ' ' THR . 41.8 mm -94.47 134.58 31.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.879 -176.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.451 HG21 ' CD1' ' A' ' 21' ' ' TYR . 69.6 m -98.11 96.25 7.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.011 175.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -101.56 158.69 15.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.988 0.423 . . . . 0.0 110.031 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -111.99 -29.29 7.69 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.126 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.82 140.02 56.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.05 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 8.9 t0 -80.01 120.69 80.59 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.755 -176.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 34' ' ' ASP . 4.4 Cg_exo . . . . . 0 N--CA 1.46 -0.486 0 C-N-CA 123.35 2.7 . . . . 0.0 112.376 177.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.589 HD23 ' HG3' ' A' ' 12' ' ' LYS . 4.6 mm? . . . . . 0 C--O 1.235 0.337 0 CA-C-O 120.608 0.242 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.581 ' HD2' ' HB2' ' A' ' 10' ' ' TRP . 11.6 Cg_exo -62.4 151.09 84.82 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.861 1.707 . . . . 0.0 109.82 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -39.68 98.28 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.801 3.001 . . . . 0.0 114.473 -174.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.96 -16.75 27.77 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.447 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.581 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 95.1 m95 -87.46 168.48 13.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.141 0.496 . . . . 0.0 112.28 -174.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.545 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 65.1 tt0 -162.07 151.86 16.41 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.433 175.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.589 ' HG3' HD23 ' A' ' 6' ' ' LEU . 53.8 mtpt -95.36 100.73 12.46 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -106.56 161.04 14.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.821 -172.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 p -104.47 138.39 40.92 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.763 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 16' ' ' SER . 17.3 t70 -97.29 -176.5 3.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.288 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.522 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 35.5 p -57.66 -56.98 14.88 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.515 0.726 . . . . 0.0 112.57 -173.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -84.24 20.28 1.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.783 0.325 . . . . 0.0 111.649 -174.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.4 9.43 81.75 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.703 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -65.83 161.88 20.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.2 m -124.89 132.24 71.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 120.938 0.399 . . . . 0.0 110.099 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -139.93 174.16 10.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.008 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.55 ' CE2' ' HG2' ' A' ' 12' ' ' LYS . 58.9 m-85 -115.78 121.99 44.1 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.892 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 3.1 p -110.45 142.73 22.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.679 -175.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -106.07 111.79 24.56 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.483 ' CE1' ' HB2' ' A' ' 11' ' ' GLU . 27.9 m80 -65.07 -36.53 84.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.284 -173.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -62.13 -62.59 1.66 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.936 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.798 HG22 HG12 ' A' ' 29' ' ' ILE . 5.3 t -104.26 8.14 36.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.08 0.467 . . . . 0.0 111.677 -176.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 60.04 45.57 11.84 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.435 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.798 HG12 HG22 ' A' ' 27' ' ' THR . 44.0 mm -96.68 134.31 34.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.186 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.6 m -108.35 122.79 47.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.663 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -127.13 154.15 45.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.426 0.632 . . . . 0.0 110.556 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -99.61 -34.3 10.27 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.412 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -88.18 152.17 22.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.883 0.373 . . . . 0.0 111.4 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -70.71 121.77 84.73 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.018 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.564 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 17.3 Cg_exo . . . . . 0 C--N 1.342 0.22 0 C-N-CA 123.563 2.842 . . . . 0.0 113.447 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.647 ' HG ' ' HA ' ' A' ' 11' ' ' GLU . 3.1 mm? . . . . . 0 C--O 1.231 0.105 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.649 ' HG3' ' HB2' ' A' ' 35' ' ' PRO . 6.0 Cg_endo -54.02 143.95 59.48 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.26 1.974 . . . . 0.0 110.82 172.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -49.45 106.54 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.405 2.737 . . . . 0.0 112.874 -175.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.9 -21.19 9.04 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.109 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.62 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 97.6 m95 -98.7 166.22 11.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.695 0.284 . . . . 0.0 111.35 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.647 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 10.0 tp10 -167.7 155.14 8.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.181 169.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.579 ' HG3' HD21 ' A' ' 6' ' ' LEU . 38.2 mtpt -93.33 95.06 9.09 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.419 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.55 ' HD3' HG13 ' A' ' 23' ' ' VAL . 3.5 mpt_? -98.56 -175.6 3.13 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.472 174.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 16.5 p -129.66 131.31 46.36 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.76 -171.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.429 ' OD1' ' HD2' ' A' ' 21' ' ' TYR . 1.1 m-20 -79.65 178.19 8.34 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.108 0.48 . . . . 0.0 109.709 173.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.0 p -74.63 -3.27 30.22 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.764 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.419 ' OD1' ' HB2' ' A' ' 19' ' ' ARG . 10.9 p30 -102.06 -1.16 32.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.989 0.423 . . . . 0.0 110.485 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.72 -3.17 67.71 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.068 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 14' ' ' THR . 2.6 mtt180 -68.69 160.71 29.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.906 0.384 . . . . 0.0 111.149 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 12.1 m -120.08 108.26 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.607 174.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.429 ' HD2' ' OD1' ' A' ' 15' ' ' ASP . 25.2 p90 -104.18 157.47 17.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.227 0.537 . . . . 0.0 110.964 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.44 ' CE2' ' HG2' ' A' ' 12' ' ' LYS . 49.6 m-85 -101.97 110.81 22.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.474 -177.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.55 HG13 ' HD3' ' A' ' 13' ' ' ARG . 7.6 p -105.56 124.22 60.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.717 -173.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -93.33 120.14 33.28 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -77.19 -20.88 54.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.517 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -76.15 -50.71 13.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.161 0.505 . . . . 0.0 110.724 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.6 p -104.87 -3.13 23.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.334 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.515 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 4.5 mpt_? 60.58 40.1 17.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.785 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.0 mm -96.94 118.04 42.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.477 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -93.74 95.15 8.97 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.679 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.407 ' OE1' ' HB2' ' A' ' 33' ' ' GLU . 4.7 tt0 -99.64 151.79 20.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.633 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -103.76 -14.3 16.12 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.14 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.407 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 13.0 mm-40 -87.71 140.93 29.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.129 -178.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.481 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 23.5 t70 -78.66 117.83 68.83 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.746 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.649 ' HB2' ' HG3' ' A' ' 7' ' ' PRO . 5.7 Cg_exo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 123.568 2.845 . . . . 0.0 112.834 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.845 HD21 ' HG3' ' A' ' 12' ' ' LYS . 3.6 mm? . . . . . 0 C--O 1.232 0.147 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.722 ' HG3' ' HB2' ' A' ' 35' ' ' PRO . 3.1 Cg_endo -49.17 134.4 30.32 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.556 2.171 . . . . 0.0 110.457 176.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -42.66 98.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.716 2.944 . . . . 0.0 113.408 -171.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 24' ' ' ASN . . . 128.42 -24.51 4.96 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.117 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.626 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 97.3 m95 -91.11 165.27 13.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.799 0.333 . . . . 0.0 111.535 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.552 ' HB3' HG13 ' A' ' 23' ' ' VAL . 71.9 tt0 -162.19 151.0 15.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.625 175.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.845 ' HG3' HD21 ' A' ' 6' ' ' LEU . 34.0 mtmt -97.7 98.08 9.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.438 0.637 . . . . 0.0 109.334 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.402 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 9.9 mtm180 -105.48 160.28 15.27 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.483 -172.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.1 p -95.05 140.93 29.31 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.474 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 16' ' ' SER . 30.5 t70 -93.4 175.54 6.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.036 -177.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.483 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 30.0 p -65.41 -33.84 76.9 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.63 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -92.13 13.12 19.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.537 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.44 -1.06 89.16 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.251 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -72.73 -174.72 1.49 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.942 0.401 . . . . 0.0 111.008 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.8 m -133.31 124.41 48.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.144 0.497 . . . . 0.0 110.521 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.436 ' HE2' ' HA ' ' A' ' 15' ' ' ASP . 41.5 p90 -119.15 167.07 12.17 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.63 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 79.0 m-85 -110.87 113.36 25.87 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 6.1 p -99.9 141.33 17.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.578 -173.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 21.7 t-20 -112.35 117.32 32.13 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -80.23 -19.57 46.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.484 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -81.78 -63.5 1.38 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.546 -175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.668 HG21 HG12 ' A' ' 29' ' ' ILE . 13.1 t -95.32 -2.37 49.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.2 0.524 . . . . 0.0 110.974 -176.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 23.6 mmt180 63.42 67.88 0.63 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.943 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.668 HG12 HG21 ' A' ' 27' ' ' THR . 38.1 mm -122.96 130.98 74.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.201 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.3 m -109.16 95.22 5.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.104 0.478 . . . . 0.0 110.219 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -102.13 172.8 6.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.309 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -120.84 6.18 10.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.964 0.412 . . . . 0.0 110.193 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -99.56 139.64 34.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.107 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.439 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 10.7 t0 -83.56 116.7 65.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.872 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.722 ' HB2' ' HG3' ' A' ' 7' ' ' PRO . 6.5 Cg_exo . . . . . 0 CA--C 1.532 0.404 0 C-N-CA 123.512 2.808 . . . . 0.0 114.295 -176.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.762 HD22 ' HG3' ' A' ' 12' ' ' LYS . 4.5 mm? . . . . . 0 CA--C 1.516 -0.347 0 CA-C-O 120.664 0.269 . . . . 0.0 110.75 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 10' ' ' TRP . 16.6 Cg_exo -66.01 149.05 86.31 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.576 2.184 . . . . 0.0 109.983 175.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -54.78 100.61 0.07 OUTLIER 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.349 2.7 . . . . 0.0 113.312 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.485 ' HA3' ' ND2' ' A' ' 26' ' ' ASN . . . 124.56 -19.68 7.04 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.693 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.708 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 97.1 m95 -99.98 162.63 12.87 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.532 0.333 . . . . 0.0 110.769 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 9.6 tp10 -168.09 156.64 9.0 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.762 ' HG3' HD22 ' A' ' 6' ' ' LEU . 23.7 mtmm -95.81 88.23 4.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -92.78 152.64 19.35 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.816 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.1 p -94.32 131.32 40.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.67 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.535 ' CG ' ' H ' ' A' ' 16' ' ' SER . 24.1 t0 -86.03 -178.3 6.51 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.244 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.535 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 57.1 p -58.73 -50.5 73.66 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.039 -173.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -93.9 28.78 2.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.759 -172.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.13 -6.19 80.27 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.532 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.05 167.07 1.79 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.944 0.402 . . . . 0.0 111.33 174.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.9 m -129.08 137.67 56.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.411 ' CD1' HG22 ' A' ' 30' ' ' THR . 52.0 p90 -140.02 161.3 37.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.127 0.489 . . . . 0.0 110.298 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 85.3 m-85 -103.41 114.18 28.25 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.684 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 9.9 p -97.28 136.13 29.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.564 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 53.7 t-20 -114.45 97.88 6.57 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 171.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -76.77 -11.7 59.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.113 0.482 . . . . 0.0 111.479 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.485 ' ND2' ' HA3' ' A' ' 9' ' ' GLY . 72.6 m-20 -66.02 -62.71 1.34 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.838 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.0 p -96.06 2.35 53.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.665 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 64.57 40.75 5.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.008 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.1 mm -105.35 128.12 59.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.198 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.411 HG22 ' CD1' ' A' ' 21' ' ' TYR . 40.5 m -96.48 109.3 21.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.897 173.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -111.2 161.35 16.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.135 0.493 . . . . 0.0 110.239 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -116.76 -22.44 8.58 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.519 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -85.82 159.1 19.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.922 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 26.6 t70 -77.46 126.63 84.47 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.096 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.458 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 17.4 Cg_exo . . . . . 0 C--N 1.345 0.349 0 C-N-CA 123.772 2.981 . . . . 0.0 113.059 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.718 HD22 ' HG3' ' A' ' 12' ' ' LYS . 3.6 mm? . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.634 0.254 . . . . 0.0 110.334 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.721 ' HG2' ' CD1' ' A' ' 10' ' ' TRP . 14.5 Cg_endo -58.98 147.91 87.64 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.599 2.199 . . . . 0.0 110.789 170.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.14 100.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.526 2.817 . . . . 0.0 113.309 -175.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 24' ' ' ASN . . . 125.91 -18.76 6.61 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.491 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.721 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 95.5 m95 -96.25 166.93 11.49 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -174.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.606 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -162.2 155.21 20.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.718 ' HG3' HD22 ' A' ' 6' ' ' LEU . 37.2 mtmt -98.95 70.65 1.84 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.402 ' HG2' ' OE1' ' A' ' 11' ' ' GLU . 14.4 mtm180 -83.54 159.06 21.75 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.901 -172.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.5 p -108.56 158.29 17.7 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.707 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -108.6 -174.25 2.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.179 0.514 . . . . 0.0 110.794 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.3 p -77.38 -4.67 46.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.71 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -94.41 -30.91 14.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.504 0.669 . . . . 0.0 109.694 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.02 15.84 8.88 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -96.75 164.72 12.45 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.274 -0.463 . . . . 0.0 110.759 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.19 132.79 62.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.118 0.485 . . . . 0.0 110.892 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.33 156.45 46.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.72 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 86.3 m-85 -97.81 121.81 40.17 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.81 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 4.8 p -106.77 136.34 42.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.188 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 26.0 t-20 -108.79 121.66 45.53 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -82.1 -26.28 33.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.727 0.298 . . . . 0.0 111.302 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.27 -57.08 9.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.392 -174.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.711 HG21 HG12 ' A' ' 29' ' ' ILE . 3.7 t -119.0 11.55 12.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.168 0.508 . . . . 0.0 111.48 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 20.3 mmt180 60.96 63.42 1.27 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.942 175.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.711 HG12 HG21 ' A' ' 27' ' ' THR . 49.1 mm -111.71 121.16 63.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.312 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.7 m -102.08 102.19 12.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -119.54 142.51 48.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.392 0.615 . . . . 0.0 110.973 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -93.74 -24.15 17.93 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.877 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.1 147.87 34.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.33 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 9.8 t0 -76.35 121.0 84.1 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 34' ' ' ASP . 18.5 Cg_exo . . . . . 0 C--N 1.344 0.324 0 C-N-CA 123.022 2.481 . . . . 0.0 112.112 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.598 ' HG ' ' HA ' ' A' ' 11' ' ' GLU . 4.5 mm? . . . . . 0 C--O 1.235 0.316 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.766 ' HG3' ' HB2' ' A' ' 35' ' ' PRO . 12.0 Cg_endo -53.9 127.83 27.21 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 121.814 1.676 . . . . 0.0 110.567 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -34.4 98.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 124.576 3.518 . . . . 0.0 114.445 -169.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.67 -19.83 6.17 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.222 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.708 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 94.4 m95 -94.6 164.02 13.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.83 0.348 . . . . 0.0 111.53 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.598 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 9.7 tp10 -162.7 153.7 17.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.878 171.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.599 ' HG2' ' CE2' ' A' ' 22' ' ' PHE . 52.3 mtpt -93.33 95.15 9.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.423 0.63 . . . . 0.0 110.399 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 6.7 mtt180 -89.44 166.13 13.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.211 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.8 OUTLIER -120.63 143.44 48.68 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.958 176.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -94.94 -168.94 1.9 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.59 0.233 . . . . 0.0 110.736 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.8 p -67.72 -20.57 65.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.888 0.375 . . . . 0.0 111.588 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -89.7 -27.84 19.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.557 0.694 . . . . 0.0 109.614 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.54 12.58 18.87 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.355 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 14' ' ' THR . 8.2 mtt180 -85.11 153.58 22.6 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 15.7 m -97.95 123.96 50.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.417 0.627 . . . . 0.0 111.347 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -123.58 146.74 47.92 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.122 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.599 ' CE2' ' HG2' ' A' ' 12' ' ' LYS . 62.9 m-85 -95.61 117.44 30.46 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.098 0.475 . . . . 0.0 110.213 -173.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 7.1 p -103.61 131.57 51.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.803 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.58 ' HB3' ' H ' ' A' ' 29' ' ' ILE . 26.8 t-20 -103.56 116.53 32.54 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -79.19 -19.23 51.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.636 0.255 . . . . 0.0 110.985 -174.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -69.43 -62.84 1.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.294 -175.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.661 HG23 HG12 ' A' ' 29' ' ' ILE . 14.4 t -117.93 15.01 14.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.681 0.753 . . . . 0.0 111.121 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 11.4 mmt180 60.38 61.14 1.84 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.563 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.661 HG12 HG23 ' A' ' 27' ' ' THR . 49.5 mm -104.01 117.08 48.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.899 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.0 m -96.05 98.32 10.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -101.71 161.9 13.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.738 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -118.01 -7.58 10.84 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.527 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.73 148.09 34.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.923 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 33.2 t70 -68.2 121.82 81.71 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.096 -173.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.766 ' HB2' ' HG3' ' A' ' 7' ' ' PRO . 6.9 Cg_exo . . . . . 0 N--CA 1.463 -0.313 0 C-N-CA 123.585 2.856 . . . . 0.0 112.239 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.465 HD22 ' HG3' ' A' ' 12' ' ' LYS . 4.1 mm? . . . . . 0 N--CA 1.454 -0.249 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.61 ' HG2' ' CD1' ' A' ' 10' ' ' TRP . 18.3 Cg_endo -59.7 134.6 58.57 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.961 1.774 . . . . 0.0 110.339 174.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.69 110.75 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.518 2.812 . . . . 0.0 113.068 -176.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.86 -29.1 5.92 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.881 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.61 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 97.7 m95 -98.18 159.29 15.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.031 0.443 . . . . 0.0 112.109 -174.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -161.31 149.1 15.26 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.049 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.465 ' HG3' HD22 ' A' ' 6' ' ' LEU . 55.4 mtpt -94.87 105.68 17.62 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.846 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -120.39 152.13 38.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.907 -172.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 40.0 p -90.08 148.7 22.87 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.026 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -96.32 -166.44 1.42 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.683 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.2 p -68.29 -17.08 64.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.763 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -90.86 -42.36 10.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.95 18.84 2.82 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.234 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 14' ' ' THR . 15.5 mtt180 -95.37 149.76 21.02 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.2 m -96.22 109.14 22.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.653 0.739 . . . . 0.0 111.258 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -101.81 174.91 5.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.289 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.416 ' CE1' ' HG2' ' A' ' 12' ' ' LYS . 69.4 m-85 -112.5 109.31 18.81 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.369 0.604 . . . . 0.0 109.818 -177.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 8.2 p -94.76 137.96 21.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.33 -176.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 27.1 t-20 -105.91 115.01 29.5 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 172.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -75.94 -21.03 57.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.83 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -73.62 -65.63 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.92 0.39 . . . . 0.0 111.221 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.771 HG21 HG12 ' A' ' 29' ' ' ILE . 6.4 t -102.03 4.55 39.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.263 0.554 . . . . 0.0 111.262 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 19.2 mmt180 59.21 63.78 1.52 Allowed 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.95 178.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.771 HG12 HG21 ' A' ' 27' ' ' THR . 45.5 mm -113.33 127.28 70.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.889 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -101.45 100.37 10.81 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.568 ' HG3' HG23 ' A' ' 29' ' ' ILE . 17.7 mt-30 -111.59 155.24 23.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.961 0.41 . . . . 0.0 110.89 -177.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -103.23 -9.62 19.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.684 0.754 . . . . 0.0 109.174 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -80.38 148.18 30.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.889 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.481 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 9.1 t70 -80.74 122.92 82.67 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.461 -176.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 34' ' ' ASP . 5.6 Cg_exo . . . . . 0 C--N 1.344 0.332 0 C-N-CA 123.645 2.897 . . . . 0.0 113.599 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.45 70.05 0.69 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.261 0.553 . . . . 0.0 110.683 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -80.01 21.9 0.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.318 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.5 163.94 18.87 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.021 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.45 168.35 24.98 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.233 2.622 . . . . 0.0 111.474 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.781 HD23 ' HG3' ' A' ' 12' ' ' LYS . 4.2 mm? -73.95 138.94 76.22 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.331 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.905 ' HD3' ' HD3' ' A' ' 36' ' ' ARG . 5.9 Cg_exo -53.49 142.22 59.83 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.916 2.411 . . . . 0.0 110.809 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -40.91 97.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.041 3.161 . . . . 0.0 114.261 -172.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.61 -27.34 4.97 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.345 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.595 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 95.7 m95 -85.55 163.49 18.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.472 0.177 . . . . 0.0 111.447 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.579 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 10.1 tp10 -163.61 152.18 13.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.096 173.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.781 ' HG3' HD23 ' A' ' 6' ' ' LEU . 30.0 mtmt -91.79 100.92 13.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.355 0.598 . . . . 0.0 109.594 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -111.22 163.68 13.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.146 -173.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.3 p -114.39 147.73 38.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.124 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -94.94 -169.38 1.99 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.622 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.4 p -71.31 -24.87 62.21 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.409 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.91 -25.8 14.88 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.045 -171.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.42 14.79 2.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.054 -1.069 . . . . 0.0 113.003 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -87.28 153.73 21.25 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.862 -0.199 . . . . 0.0 110.483 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.8 m -104.22 121.98 56.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.19 0.519 . . . . 0.0 110.169 174.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.451 ' CD1' HG21 ' A' ' 30' ' ' THR . 43.2 p90 -124.69 171.64 9.91 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.806 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 80.2 m-85 -117.23 118.16 31.55 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.779 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 9.8 p -96.83 131.73 42.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.652 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -101.1 115.86 31.47 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -66.95 -32.73 74.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.82 -178.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -66.46 -61.2 2.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.652 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.55 ' HB ' HG12 ' A' ' 29' ' ' ILE . 11.2 p -87.28 -13.87 42.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.767 -176.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 66.13 33.29 7.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.423 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.55 HG12 ' HB ' ' A' ' 27' ' ' THR . 41.8 mm -94.47 134.58 31.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.879 -176.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.451 HG21 ' CD1' ' A' ' 21' ' ' TYR . 69.6 m -98.11 96.25 7.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.011 175.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -101.56 158.69 15.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.988 0.423 . . . . 0.0 110.031 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -111.99 -29.29 7.69 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.126 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.82 140.02 56.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.05 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 8.9 t0 -80.01 120.69 80.59 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.755 -176.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 34' ' ' ASP . 4.4 Cg_exo -76.62 -21.71 12.69 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.35 2.7 . . . . 0.0 112.376 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.905 ' HD3' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -91.81 42.68 1.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.359 0.6 . . . . 0.0 110.978 -178.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 C--O 1.247 0.966 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.896 -179.431 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.83 124.37 48.22 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.9 mtp -101.33 137.47 39.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.109 0.48 . . . . 0.0 111.454 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.0 -130.84 7.97 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.364 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.18 -157.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 124.168 3.245 . . . . 0.0 112.471 173.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.589 HD23 ' HG3' ' A' ' 12' ' ' LYS . 4.6 mm? -56.72 164.27 2.26 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.621 172.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.581 ' HD2' ' HB2' ' A' ' 10' ' ' TRP . 11.6 Cg_exo -62.4 151.09 84.82 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.861 1.707 . . . . 0.0 109.82 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -39.68 98.28 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.801 3.001 . . . . 0.0 114.473 -174.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.96 -16.75 27.77 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.447 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.581 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 95.1 m95 -87.46 168.48 13.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.141 0.496 . . . . 0.0 112.28 -174.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.545 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 65.1 tt0 -162.07 151.86 16.41 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.433 175.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.589 ' HG3' HD23 ' A' ' 6' ' ' LEU . 53.8 mtpt -95.36 100.73 12.46 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -106.56 161.04 14.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.821 -172.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 p -104.47 138.39 40.92 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.763 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 16' ' ' SER . 17.3 t70 -97.29 -176.5 3.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.288 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.522 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 35.5 p -57.66 -56.98 14.88 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.515 0.726 . . . . 0.0 112.57 -173.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -84.24 20.28 1.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.783 0.325 . . . . 0.0 111.649 -174.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.4 9.43 81.75 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.703 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -65.83 161.88 20.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.2 m -124.89 132.24 71.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 120.938 0.399 . . . . 0.0 110.099 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -139.93 174.16 10.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.008 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.55 ' CE2' ' HG2' ' A' ' 12' ' ' LYS . 58.9 m-85 -115.78 121.99 44.1 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.892 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 3.1 p -110.45 142.73 22.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.679 -175.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -106.07 111.79 24.56 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.483 ' CE1' ' HB2' ' A' ' 11' ' ' GLU . 27.9 m80 -65.07 -36.53 84.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.284 -173.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -62.13 -62.59 1.66 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.936 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.798 HG22 HG12 ' A' ' 29' ' ' ILE . 5.3 t -104.26 8.14 36.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.08 0.467 . . . . 0.0 111.677 -176.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 60.04 45.57 11.84 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.435 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.798 HG12 HG22 ' A' ' 27' ' ' THR . 44.0 mm -96.68 134.31 34.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.186 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.6 m -108.35 122.79 47.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.663 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -127.13 154.15 45.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.426 0.632 . . . . 0.0 110.556 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -99.61 -34.3 10.27 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.412 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -88.18 152.17 22.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.883 0.373 . . . . 0.0 111.4 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -70.71 121.77 84.73 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.018 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.564 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 17.3 Cg_exo -70.92 -18.33 31.64 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.563 2.842 . . . . 0.0 113.447 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -93.19 66.68 4.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.39 0.614 . . . . 0.0 112.05 -173.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.248 1.023 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.633 174.674 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 3' ' ' MET . . . -80.33 102.58 9.65 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 61.7 mtt 67.04 -84.6 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 123.726 0.641 . . . . 0.0 110.776 -173.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.14 106.09 3.08 Favored Glycine 0 C--N 1.303 -1.26 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.671 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -53.02 144.58 45.29 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.579 2.853 . . . . 0.0 112.888 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.647 ' HG ' ' HA ' ' A' ' 11' ' ' GLU . 3.1 mm? -82.34 160.04 63.24 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.117 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.649 ' HG3' ' HB2' ' A' ' 35' ' ' PRO . 6.0 Cg_endo -54.02 143.95 59.48 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.26 1.974 . . . . 0.0 110.82 172.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -49.45 106.54 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.405 2.737 . . . . 0.0 112.874 -175.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.9 -21.19 9.04 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.109 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.62 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 97.6 m95 -98.7 166.22 11.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.695 0.284 . . . . 0.0 111.35 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.647 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 10.0 tp10 -167.7 155.14 8.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.181 169.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.579 ' HG3' HD21 ' A' ' 6' ' ' LEU . 38.2 mtpt -93.33 95.06 9.09 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.419 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.55 ' HD3' HG13 ' A' ' 23' ' ' VAL . 3.5 mpt_? -98.56 -175.6 3.13 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.472 174.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 16.5 p -129.66 131.31 46.36 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.76 -171.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.429 ' OD1' ' HD2' ' A' ' 21' ' ' TYR . 1.1 m-20 -79.65 178.19 8.34 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.108 0.48 . . . . 0.0 109.709 173.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.0 p -74.63 -3.27 30.22 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.764 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.419 ' OD1' ' HB2' ' A' ' 19' ' ' ARG . 10.9 p30 -102.06 -1.16 32.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.989 0.423 . . . . 0.0 110.485 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.72 -3.17 67.71 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.068 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 14' ' ' THR . 2.6 mtt180 -68.69 160.71 29.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.906 0.384 . . . . 0.0 111.149 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 12.1 m -120.08 108.26 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.607 174.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.429 ' HD2' ' OD1' ' A' ' 15' ' ' ASP . 25.2 p90 -104.18 157.47 17.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.227 0.537 . . . . 0.0 110.964 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.44 ' CE2' ' HG2' ' A' ' 12' ' ' LYS . 49.6 m-85 -101.97 110.81 22.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.474 -177.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.55 HG13 ' HD3' ' A' ' 13' ' ' ARG . 7.6 p -105.56 124.22 60.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.717 -173.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -93.33 120.14 33.28 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -77.19 -20.88 54.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.517 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -76.15 -50.71 13.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.161 0.505 . . . . 0.0 110.724 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.6 p -104.87 -3.13 23.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.334 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.515 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 4.5 mpt_? 60.58 40.1 17.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.785 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.0 mm -96.94 118.04 42.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.477 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -93.74 95.15 8.97 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.679 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.407 ' OE1' ' HB2' ' A' ' 33' ' ' GLU . 4.7 tt0 -99.64 151.79 20.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.633 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -103.76 -14.3 16.12 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.14 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.407 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 13.0 mm-40 -87.71 140.93 29.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.129 -178.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.481 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 23.5 t70 -78.66 117.83 68.83 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.746 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.649 ' HB2' ' HG3' ' A' ' 7' ' ' PRO . 5.7 Cg_exo -81.44 -11.29 11.86 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.568 2.845 . . . . 0.0 112.834 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -81.97 48.29 1.21 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.979 -172.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.252 1.207 0 CA-C-O 119.067 -0.492 . . . . 0.0 110.534 179.453 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.65 12.96 19.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.287 0.565 . . . . 0.0 110.908 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.8 mtp -102.0 150.13 23.54 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.797 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.28 138.96 6.05 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.344 -0.931 . . . . 0.0 112.28 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -45.75 150.7 1.51 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 124.134 3.223 . . . . 0.0 112.996 172.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.845 HD21 ' HG3' ' A' ' 12' ' ' LYS . 3.6 mm? -67.26 149.46 98.42 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.447 176.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.722 ' HG3' ' HB2' ' A' ' 35' ' ' PRO . 3.1 Cg_endo -49.17 134.4 30.32 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.556 2.171 . . . . 0.0 110.457 176.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -42.66 98.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.716 2.944 . . . . 0.0 113.408 -171.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 24' ' ' ASN . . . 128.42 -24.51 4.96 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.117 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.626 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 97.3 m95 -91.11 165.27 13.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.799 0.333 . . . . 0.0 111.535 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.552 ' HB3' HG13 ' A' ' 23' ' ' VAL . 71.9 tt0 -162.19 151.0 15.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.625 175.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.845 ' HG3' HD21 ' A' ' 6' ' ' LEU . 34.0 mtmt -97.7 98.08 9.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.438 0.637 . . . . 0.0 109.334 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.402 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 9.9 mtm180 -105.48 160.28 15.27 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.483 -172.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.1 p -95.05 140.93 29.31 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.474 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 16' ' ' SER . 30.5 t70 -93.4 175.54 6.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.036 -177.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.483 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 30.0 p -65.41 -33.84 76.9 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.63 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -92.13 13.12 19.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.537 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.44 -1.06 89.16 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.251 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -72.73 -174.72 1.49 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.942 0.401 . . . . 0.0 111.008 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.8 m -133.31 124.41 48.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.144 0.497 . . . . 0.0 110.521 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.436 ' HE2' ' HA ' ' A' ' 15' ' ' ASP . 41.5 p90 -119.15 167.07 12.17 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.63 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 79.0 m-85 -110.87 113.36 25.87 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 6.1 p -99.9 141.33 17.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.578 -173.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 21.7 t-20 -112.35 117.32 32.13 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -80.23 -19.57 46.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.484 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -81.78 -63.5 1.38 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.546 -175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.668 HG21 HG12 ' A' ' 29' ' ' ILE . 13.1 t -95.32 -2.37 49.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.2 0.524 . . . . 0.0 110.974 -176.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 23.6 mmt180 63.42 67.88 0.63 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.943 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.668 HG12 HG21 ' A' ' 27' ' ' THR . 38.1 mm -122.96 130.98 74.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.201 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.3 m -109.16 95.22 5.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.104 0.478 . . . . 0.0 110.219 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -102.13 172.8 6.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.309 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -120.84 6.18 10.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.964 0.412 . . . . 0.0 110.193 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -99.56 139.64 34.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.107 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.439 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 10.7 t0 -83.56 116.7 65.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.872 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.722 ' HB2' ' HG3' ' A' ' 7' ' ' PRO . 6.5 Cg_exo -78.54 -11.86 15.5 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.512 2.808 . . . . 0.0 114.295 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -81.99 53.71 2.28 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -168.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 C--O 1.253 1.263 0 CA-C-O 118.14 -0.933 . . . . 0.0 110.119 174.839 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 112.239 -0.344 . . . . 0.0 112.239 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.52 38.49 29.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.015 0.436 . . . . 0.0 111.271 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.5 mtt -147.59 151.68 36.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.544 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.2 -76.27 1.18 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 172.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -78.97 178.21 7.81 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.238 2.625 . . . . 0.0 111.799 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.762 HD22 ' HG3' ' A' ' 12' ' ' LYS . 4.5 mm? -78.84 166.77 40.09 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.75 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 10' ' ' TRP . 16.6 Cg_exo -66.01 149.05 86.31 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.576 2.184 . . . . 0.0 109.983 175.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -54.78 100.61 0.07 OUTLIER 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.349 2.7 . . . . 0.0 113.312 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.485 ' HA3' ' ND2' ' A' ' 26' ' ' ASN . . . 124.56 -19.68 7.04 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.693 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.708 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 97.1 m95 -99.98 162.63 12.87 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.532 0.333 . . . . 0.0 110.769 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 9.6 tp10 -168.09 156.64 9.0 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.762 ' HG3' HD22 ' A' ' 6' ' ' LEU . 23.7 mtmm -95.81 88.23 4.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -92.78 152.64 19.35 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.816 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.1 p -94.32 131.32 40.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.67 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.535 ' CG ' ' H ' ' A' ' 16' ' ' SER . 24.1 t0 -86.03 -178.3 6.51 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.244 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.535 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 57.1 p -58.73 -50.5 73.66 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.039 -173.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -93.9 28.78 2.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.759 -172.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.13 -6.19 80.27 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.532 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.05 167.07 1.79 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.944 0.402 . . . . 0.0 111.33 174.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.9 m -129.08 137.67 56.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.411 ' CD1' HG22 ' A' ' 30' ' ' THR . 52.0 p90 -140.02 161.3 37.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.127 0.489 . . . . 0.0 110.298 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 85.3 m-85 -103.41 114.18 28.25 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.684 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 9.9 p -97.28 136.13 29.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.564 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 53.7 t-20 -114.45 97.88 6.57 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 171.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -76.77 -11.7 59.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.113 0.482 . . . . 0.0 111.479 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.485 ' ND2' ' HA3' ' A' ' 9' ' ' GLY . 72.6 m-20 -66.02 -62.71 1.34 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.838 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.0 p -96.06 2.35 53.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.665 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 64.57 40.75 5.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.008 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.1 mm -105.35 128.12 59.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.198 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.411 HG22 ' CD1' ' A' ' 21' ' ' TYR . 40.5 m -96.48 109.3 21.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.897 173.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -111.2 161.35 16.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.135 0.493 . . . . 0.0 110.239 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -116.76 -22.44 8.58 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.519 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -85.82 159.1 19.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.922 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 26.6 t70 -77.46 126.63 84.47 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.096 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.458 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 17.4 Cg_exo -70.38 -27.22 23.76 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.772 2.981 . . . . 0.0 113.059 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.527 HH21 HD21 ' A' ' 6' ' ' LEU . 11.0 mtt85 -79.77 -15.73 56.91 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.684 0.278 . . . . 0.0 110.709 -176.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.5 p . . . . . 0 C--O 1.249 1.046 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.072 177.898 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 112.246 -0.342 . . . . 0.0 112.246 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.18 88.83 6.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.185 0.517 . . . . 0.0 110.018 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.3 mtt -91.05 17.27 8.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.147 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.97 136.85 46.06 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.832 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.35 171.0 18.88 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.066 2.511 . . . . 0.0 112.092 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.718 HD22 ' HG3' ' A' ' 12' ' ' LYS . 3.6 mm? -100.46 155.5 36.31 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.334 177.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.721 ' HG2' ' CD1' ' A' ' 10' ' ' TRP . 14.5 Cg_endo -58.98 147.91 87.64 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.599 2.199 . . . . 0.0 110.789 170.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.14 100.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.526 2.817 . . . . 0.0 113.309 -175.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 24' ' ' ASN . . . 125.91 -18.76 6.61 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.491 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.721 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 95.5 m95 -96.25 166.93 11.49 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -174.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.606 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -162.2 155.21 20.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.718 ' HG3' HD22 ' A' ' 6' ' ' LEU . 37.2 mtmt -98.95 70.65 1.84 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.402 ' HG2' ' OE1' ' A' ' 11' ' ' GLU . 14.4 mtm180 -83.54 159.06 21.75 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.901 -172.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.5 p -108.56 158.29 17.7 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.707 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -108.6 -174.25 2.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.179 0.514 . . . . 0.0 110.794 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.3 p -77.38 -4.67 46.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.71 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -94.41 -30.91 14.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.504 0.669 . . . . 0.0 109.694 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.02 15.84 8.88 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -96.75 164.72 12.45 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.274 -0.463 . . . . 0.0 110.759 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.19 132.79 62.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.118 0.485 . . . . 0.0 110.892 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.33 156.45 46.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.72 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 86.3 m-85 -97.81 121.81 40.17 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.81 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 4.8 p -106.77 136.34 42.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.188 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 26.0 t-20 -108.79 121.66 45.53 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -82.1 -26.28 33.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.727 0.298 . . . . 0.0 111.302 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.27 -57.08 9.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.392 -174.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.711 HG21 HG12 ' A' ' 29' ' ' ILE . 3.7 t -119.0 11.55 12.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.168 0.508 . . . . 0.0 111.48 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 20.3 mmt180 60.96 63.42 1.27 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.942 175.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.711 HG12 HG21 ' A' ' 27' ' ' THR . 49.1 mm -111.71 121.16 63.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.312 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.7 m -102.08 102.19 12.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -119.54 142.51 48.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.392 0.615 . . . . 0.0 110.973 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -93.74 -24.15 17.93 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.877 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.1 147.87 34.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.33 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 9.8 t0 -76.35 121.0 84.1 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 34' ' ' ASP . 18.5 Cg_exo -65.87 -22.7 55.9 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.022 2.481 . . . . 0.0 112.112 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.419 ' HG2' ' HD3' ' A' ' 7' ' ' PRO . 47.4 mtm180 -96.43 -5.42 39.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.349 -170.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--O 1.244 0.768 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.056 -179.966 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.17 19.23 10.76 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.107 0.563 . . . . 0.0 112.124 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.8 mtp -88.22 89.26 7.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.18 145.11 9.25 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.456 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -80.12 131.08 8.62 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.527 2.151 . . . . 0.0 112.768 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.598 ' HG ' ' HA ' ' A' ' 11' ' ' GLU . 4.5 mm? -64.39 150.49 93.06 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 168.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.766 ' HG3' ' HB2' ' A' ' 35' ' ' PRO . 12.0 Cg_endo -53.9 127.83 27.21 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 121.814 1.676 . . . . 0.0 110.567 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -34.4 98.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 124.576 3.518 . . . . 0.0 114.445 -169.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.67 -19.83 6.17 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.222 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.708 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 94.4 m95 -94.6 164.02 13.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.83 0.348 . . . . 0.0 111.53 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.598 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 9.7 tp10 -162.7 153.7 17.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.878 171.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.599 ' HG2' ' CE2' ' A' ' 22' ' ' PHE . 52.3 mtpt -93.33 95.15 9.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.423 0.63 . . . . 0.0 110.399 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 6.7 mtt180 -89.44 166.13 13.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.211 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.8 OUTLIER -120.63 143.44 48.68 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.958 176.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -94.94 -168.94 1.9 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.59 0.233 . . . . 0.0 110.736 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.8 p -67.72 -20.57 65.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.888 0.375 . . . . 0.0 111.588 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -89.7 -27.84 19.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.557 0.694 . . . . 0.0 109.614 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.54 12.58 18.87 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.355 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 14' ' ' THR . 8.2 mtt180 -85.11 153.58 22.6 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 15.7 m -97.95 123.96 50.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.417 0.627 . . . . 0.0 111.347 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -123.58 146.74 47.92 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.122 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.599 ' CE2' ' HG2' ' A' ' 12' ' ' LYS . 62.9 m-85 -95.61 117.44 30.46 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.098 0.475 . . . . 0.0 110.213 -173.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 7.1 p -103.61 131.57 51.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.803 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.58 ' HB3' ' H ' ' A' ' 29' ' ' ILE . 26.8 t-20 -103.56 116.53 32.54 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -79.19 -19.23 51.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.636 0.255 . . . . 0.0 110.985 -174.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -69.43 -62.84 1.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.294 -175.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.661 HG23 HG12 ' A' ' 29' ' ' ILE . 14.4 t -117.93 15.01 14.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.681 0.753 . . . . 0.0 111.121 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 11.4 mmt180 60.38 61.14 1.84 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.563 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.661 HG12 HG23 ' A' ' 27' ' ' THR . 49.5 mm -104.01 117.08 48.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.899 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.0 m -96.05 98.32 10.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -101.71 161.9 13.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.738 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -118.01 -7.58 10.84 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.527 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.73 148.09 34.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.923 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 33.2 t70 -68.2 121.82 81.71 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.096 -173.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.766 ' HB2' ' HG3' ' A' ' 7' ' ' PRO . 6.9 Cg_exo -77.27 -17.73 14.65 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.585 2.856 . . . . 0.0 112.239 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.476 ' HG3' ' HD3' ' A' ' 7' ' ' PRO . 8.8 mtp180 -68.09 -73.18 0.15 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.461 -173.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.845 -175.089 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.78 130.63 2.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.329 . . . . 0.0 110.698 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.8 mtm -69.8 143.04 53.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.021 175.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.53 124.49 0.73 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.656 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -51.86 134.58 48.62 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.635 2.89 . . . . 0.0 112.568 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.465 HD22 ' HG3' ' A' ' 12' ' ' LYS . 4.1 mm? -68.42 156.91 89.4 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.77 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.61 ' HG2' ' CD1' ' A' ' 10' ' ' TRP . 18.3 Cg_endo -59.7 134.6 58.57 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.961 1.774 . . . . 0.0 110.339 174.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.69 110.75 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.518 2.812 . . . . 0.0 113.068 -176.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.86 -29.1 5.92 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.881 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.61 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 97.7 m95 -98.18 159.29 15.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.031 0.443 . . . . 0.0 112.109 -174.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -161.31 149.1 15.26 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.049 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.465 ' HG3' HD22 ' A' ' 6' ' ' LEU . 55.4 mtpt -94.87 105.68 17.62 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.846 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -120.39 152.13 38.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.907 -172.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 40.0 p -90.08 148.7 22.87 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.026 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -96.32 -166.44 1.42 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.683 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.2 p -68.29 -17.08 64.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.763 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -90.86 -42.36 10.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.95 18.84 2.82 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.234 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 14' ' ' THR . 15.5 mtt180 -95.37 149.76 21.02 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.2 m -96.22 109.14 22.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.653 0.739 . . . . 0.0 111.258 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -101.81 174.91 5.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.289 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.416 ' CE1' ' HG2' ' A' ' 12' ' ' LYS . 69.4 m-85 -112.5 109.31 18.81 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.369 0.604 . . . . 0.0 109.818 -177.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 8.2 p -94.76 137.96 21.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.33 -176.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 27.1 t-20 -105.91 115.01 29.5 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 172.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -75.94 -21.03 57.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.83 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -73.62 -65.63 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.92 0.39 . . . . 0.0 111.221 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.771 HG21 HG12 ' A' ' 29' ' ' ILE . 6.4 t -102.03 4.55 39.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.263 0.554 . . . . 0.0 111.262 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 19.2 mmt180 59.21 63.78 1.52 Allowed 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.95 178.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.771 HG12 HG21 ' A' ' 27' ' ' THR . 45.5 mm -113.33 127.28 70.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.889 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -101.45 100.37 10.81 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.568 ' HG3' HG23 ' A' ' 29' ' ' ILE . 17.7 mt-30 -111.59 155.24 23.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.961 0.41 . . . . 0.0 110.89 -177.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -103.23 -9.62 19.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.684 0.754 . . . . 0.0 109.174 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -80.38 148.18 30.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.889 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.481 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 9.1 t70 -80.74 122.92 82.67 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.461 -176.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 34' ' ' ASP . 5.6 Cg_exo -84.54 -8.7 9.42 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.645 2.897 . . . . 0.0 113.599 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.44 ' HG3' ' HD3' ' A' ' 7' ' ' PRO . 34.9 mtp85 -88.14 51.97 2.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.336 0.589 . . . . 0.0 111.886 -174.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.328 177.315 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.848 HD21 ' HG3' ' A' ' 12' ' ' LYS . 4.2 mm? . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 120.79 0.329 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HG2' ' CD1' ' A' ' 10' ' ' TRP . 5.9 Cg_exo -53.49 142.22 59.83 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.916 2.411 . . . . 0.0 110.809 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -40.91 97.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.041 3.161 . . . . 0.0 114.261 -172.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.61 -27.34 4.97 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.345 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.608 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 95.7 m95 -85.55 163.49 18.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.472 0.177 . . . . 0.0 111.447 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.586 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 10.1 tp10 -163.61 152.18 13.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.096 173.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.848 ' HG3' HD21 ' A' ' 6' ' ' LEU . 30.0 mtmt -91.79 100.92 13.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.355 0.598 . . . . 0.0 109.594 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -111.22 163.68 13.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.146 -173.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.3 p -114.39 147.73 38.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.124 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -94.94 -169.38 1.99 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.622 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.4 p -71.31 -24.87 62.21 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.409 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.91 -25.8 14.88 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.045 -171.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.42 14.79 2.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.054 -1.069 . . . . 0.0 113.003 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -87.28 153.73 21.25 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.862 -0.199 . . . . 0.0 110.483 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.8 m -104.22 121.98 56.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.19 0.519 . . . . 0.0 110.169 174.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.457 ' CD1' HG23 ' A' ' 30' ' ' THR . 43.2 p90 -124.69 171.64 9.91 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.806 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.531 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 80.2 m-85 -117.23 118.16 31.55 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.779 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 9.8 p -96.83 131.73 42.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.652 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -101.1 115.86 31.47 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -66.95 -32.73 74.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.82 -178.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -66.46 -61.2 2.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.652 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.544 ' HB ' HG12 ' A' ' 29' ' ' ILE . 11.2 p -87.28 -13.87 42.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.767 -176.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.422 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 16.5 mmt180 66.13 33.29 7.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.423 -176.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.544 HG12 ' HB ' ' A' ' 27' ' ' THR . 41.8 mm -94.47 134.58 31.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.879 -176.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.457 HG23 ' CD1' ' A' ' 21' ' ' TYR . 69.6 m -98.11 96.25 7.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.011 175.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -101.56 158.69 15.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.988 0.423 . . . . 0.0 110.031 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -111.99 -29.29 7.69 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.126 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.82 140.02 56.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.05 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.489 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 8.9 t0 -80.01 120.69 80.59 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.755 -176.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 34' ' ' ASP . 4.4 Cg_exo . . . . . 0 N--CA 1.46 -0.486 0 C-N-CA 123.35 2.7 . . . . 0.0 112.376 177.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.59 HD21 ' HG3' ' A' ' 12' ' ' LYS . 4.6 mm? . . . . . 0 C--O 1.235 0.337 0 CA-C-O 120.608 0.242 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.629 ' HG2' ' HB2' ' A' ' 35' ' ' PRO . 11.6 Cg_exo -62.4 151.09 84.82 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.861 1.707 . . . . 0.0 109.82 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -39.68 98.28 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.801 3.001 . . . . 0.0 114.473 -174.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.96 -16.75 27.77 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.447 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.587 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 95.1 m95 -87.46 168.48 13.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.141 0.496 . . . . 0.0 112.28 -174.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.544 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 65.1 tt0 -162.07 151.86 16.41 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.433 175.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.59 ' HG3' HD21 ' A' ' 6' ' ' LEU . 53.8 mtpt -95.36 100.73 12.46 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -106.56 161.04 14.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.821 -172.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 p -104.47 138.39 40.92 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.763 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 16' ' ' SER . 17.3 t70 -97.29 -176.5 3.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.288 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.486 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 35.5 p -57.66 -56.98 14.88 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.515 0.726 . . . . 0.0 112.57 -173.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -84.24 20.28 1.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.783 0.325 . . . . 0.0 111.649 -174.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.4 9.43 81.75 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.703 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -65.83 161.88 20.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.2 m -124.89 132.24 71.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 120.938 0.399 . . . . 0.0 110.099 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -139.93 174.16 10.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.008 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.563 ' CE2' ' HG2' ' A' ' 12' ' ' LYS . 58.9 m-85 -115.78 121.99 44.1 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.892 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 3.1 p -110.45 142.73 22.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.679 -175.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -106.07 111.79 24.56 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 11' ' ' GLU . 27.9 m80 -65.07 -36.53 84.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.284 -173.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -62.13 -62.59 1.66 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.936 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.823 HG23 HG12 ' A' ' 29' ' ' ILE . 5.3 t -104.26 8.14 36.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.08 0.467 . . . . 0.0 111.677 -176.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 60.04 45.57 11.84 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.435 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.823 HG12 HG23 ' A' ' 27' ' ' THR . 44.0 mm -96.68 134.31 34.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.186 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.6 m -108.35 122.79 47.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.663 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -127.13 154.15 45.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.426 0.632 . . . . 0.0 110.556 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -99.61 -34.3 10.27 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.412 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -88.18 152.17 22.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.883 0.373 . . . . 0.0 111.4 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -70.71 121.77 84.73 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.018 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.629 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 17.3 Cg_exo . . . . . 0 C--N 1.342 0.22 0 C-N-CA 123.563 2.842 . . . . 0.0 113.447 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.678 ' HG ' ' HA ' ' A' ' 11' ' ' GLU . 3.1 mm? . . . . . 0 C--O 1.231 0.105 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.695 ' HG3' ' HB2' ' A' ' 35' ' ' PRO . 6.0 Cg_endo -54.02 143.95 59.48 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.26 1.974 . . . . 0.0 110.82 172.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 7' ' ' PRO . 71.9 Cg_exo -49.45 106.54 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.405 2.737 . . . . 0.0 112.874 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.9 -21.19 9.04 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.109 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.622 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 97.6 m95 -98.7 166.22 11.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.695 0.284 . . . . 0.0 111.35 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.678 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 10.0 tp10 -167.7 155.14 8.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.181 169.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.585 ' HG3' HD21 ' A' ' 6' ' ' LEU . 38.2 mtpt -93.33 95.06 9.09 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.419 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.582 ' HD3' HG11 ' A' ' 23' ' ' VAL . 3.5 mpt_? -98.56 -175.6 3.13 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.472 174.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 16.5 p -129.66 131.31 46.36 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.76 -171.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.428 ' OD1' ' HD2' ' A' ' 21' ' ' TYR . 1.1 m-20 -79.65 178.19 8.34 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.108 0.48 . . . . 0.0 109.709 173.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.0 p -74.63 -3.27 30.22 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.764 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.413 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 10.9 p30 -102.06 -1.16 32.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.989 0.423 . . . . 0.0 110.485 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.72 -3.17 67.71 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.068 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 14' ' ' THR . 2.6 mtt180 -68.69 160.71 29.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.906 0.384 . . . . 0.0 111.149 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 12.1 m -120.08 108.26 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.607 174.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.428 ' HD2' ' OD1' ' A' ' 15' ' ' ASP . 25.2 p90 -104.18 157.47 17.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.227 0.537 . . . . 0.0 110.964 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.464 ' CE2' ' HG2' ' A' ' 12' ' ' LYS . 49.6 m-85 -101.97 110.81 22.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.474 -177.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.582 HG11 ' HD3' ' A' ' 13' ' ' ARG . 7.6 p -105.56 124.22 60.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.717 -173.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -93.33 120.14 33.28 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -77.19 -20.88 54.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.517 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -76.15 -50.71 13.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.161 0.505 . . . . 0.0 110.724 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.6 p -104.87 -3.13 23.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.334 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.52 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 4.5 mpt_? 60.58 40.1 17.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.785 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.0 mm -96.94 118.04 42.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.477 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -93.74 95.15 8.97 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.679 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.416 ' OE1' ' HB2' ' A' ' 33' ' ' GLU . 4.7 tt0 -99.64 151.79 20.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.633 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -103.76 -14.3 16.12 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.14 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.416 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 13.0 mm-40 -87.71 140.93 29.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.129 -178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.494 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 23.5 t70 -78.66 117.83 68.83 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.746 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.695 ' HB2' ' HG3' ' A' ' 7' ' ' PRO . 5.7 Cg_exo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 123.568 2.845 . . . . 0.0 112.834 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.884 HD21 ' HG3' ' A' ' 12' ' ' LYS . 3.6 mm? . . . . . 0 C--O 1.232 0.147 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.772 ' HG3' ' HB2' ' A' ' 35' ' ' PRO . 3.1 Cg_endo -49.17 134.4 30.32 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.556 2.171 . . . . 0.0 110.457 176.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -42.66 98.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.716 2.944 . . . . 0.0 113.408 -171.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 24' ' ' ASN . . . 128.42 -24.51 4.96 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.117 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.631 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 97.3 m95 -91.11 165.27 13.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.799 0.333 . . . . 0.0 111.535 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.563 ' HB3' HG12 ' A' ' 23' ' ' VAL . 71.9 tt0 -162.19 151.0 15.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.625 175.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.884 ' HG3' HD21 ' A' ' 6' ' ' LEU . 34.0 mtmt -97.7 98.08 9.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.438 0.637 . . . . 0.0 109.334 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.411 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 9.9 mtm180 -105.48 160.28 15.27 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.483 -172.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.1 p -95.05 140.93 29.31 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.474 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HA ' ' HE2' ' A' ' 21' ' ' TYR . 30.5 t70 -93.4 175.54 6.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.036 -177.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.425 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 30.0 p -65.41 -33.84 76.9 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.63 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -92.13 13.12 19.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.537 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.44 -1.06 89.16 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.251 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -72.73 -174.72 1.49 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.942 0.401 . . . . 0.0 111.008 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.8 m -133.31 124.41 48.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.144 0.497 . . . . 0.0 110.521 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.444 ' HE2' ' HA ' ' A' ' 15' ' ' ASP . 41.5 p90 -119.15 167.07 12.17 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.63 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 79.0 m-85 -110.87 113.36 25.87 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 6.1 p -99.9 141.33 17.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.578 -173.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB3' ' H ' ' A' ' 29' ' ' ILE . 21.7 t-20 -112.35 117.32 32.13 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -80.23 -19.57 46.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.484 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -81.78 -63.5 1.38 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.546 -175.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.704 HG23 HG12 ' A' ' 29' ' ' ILE . 13.1 t -95.32 -2.37 49.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.2 0.524 . . . . 0.0 110.974 -176.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 23.6 mmt180 63.42 67.88 0.63 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.943 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.704 HG12 HG23 ' A' ' 27' ' ' THR . 38.1 mm -122.96 130.98 74.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.201 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.3 m -109.16 95.22 5.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.104 0.478 . . . . 0.0 110.219 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.418 ' HG3' HG22 ' A' ' 29' ' ' ILE . 18.1 mt-30 -102.13 172.8 6.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.309 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -120.84 6.18 10.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.964 0.412 . . . . 0.0 110.193 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -99.56 139.64 34.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.107 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 10.7 t0 -83.56 116.7 65.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.872 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.772 ' HB2' ' HG3' ' A' ' 7' ' ' PRO . 6.5 Cg_exo . . . . . 0 CA--C 1.532 0.404 0 C-N-CA 123.512 2.808 . . . . 0.0 114.295 -176.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.808 HD21 ' HG3' ' A' ' 12' ' ' LYS . 4.5 mm? . . . . . 0 CA--C 1.516 -0.347 0 CA-C-O 120.664 0.269 . . . . 0.0 110.75 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.546 ' HD2' ' HB2' ' A' ' 10' ' ' TRP . 16.6 Cg_exo -66.01 149.05 86.31 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.576 2.184 . . . . 0.0 109.983 175.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -54.78 100.61 0.07 OUTLIER 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.349 2.7 . . . . 0.0 113.312 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.503 ' HA3' ' ND2' ' A' ' 26' ' ' ASN . . . 124.56 -19.68 7.04 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.693 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.717 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 97.1 m95 -99.98 162.63 12.87 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.532 0.333 . . . . 0.0 110.769 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 9.6 tp10 -168.09 156.64 9.0 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.808 ' HG3' HD21 ' A' ' 6' ' ' LEU . 23.7 mtmm -95.81 88.23 4.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -92.78 152.64 19.35 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.816 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.1 p -94.32 131.32 40.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.67 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 16' ' ' SER . 24.1 t0 -86.03 -178.3 6.51 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.244 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.488 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 57.1 p -58.73 -50.5 73.66 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.039 -173.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -93.9 28.78 2.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.759 -172.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.13 -6.19 80.27 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.532 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.05 167.07 1.79 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.944 0.402 . . . . 0.0 111.33 174.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.9 m -129.08 137.67 56.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.419 ' CD1' HG23 ' A' ' 30' ' ' THR . 52.0 p90 -140.02 161.3 37.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.127 0.489 . . . . 0.0 110.298 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 85.3 m-85 -103.41 114.18 28.25 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.684 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.717 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 9.9 p -97.28 136.13 29.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.564 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 53.7 t-20 -114.45 97.88 6.57 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 171.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -76.77 -11.7 59.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.113 0.482 . . . . 0.0 111.479 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.503 ' ND2' ' HA3' ' A' ' 9' ' ' GLY . 72.6 m-20 -66.02 -62.71 1.34 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.838 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.0 p -96.06 2.35 53.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.665 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 64.57 40.75 5.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.008 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.1 mm -105.35 128.12 59.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.198 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.419 HG23 ' CD1' ' A' ' 21' ' ' TYR . 40.5 m -96.48 109.3 21.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.897 173.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -111.2 161.35 16.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.135 0.493 . . . . 0.0 110.239 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -116.76 -22.44 8.58 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.519 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -85.82 159.1 19.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.922 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 26.6 t70 -77.46 126.63 84.47 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.096 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.487 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 17.4 Cg_exo . . . . . 0 C--N 1.345 0.349 0 C-N-CA 123.772 2.981 . . . . 0.0 113.059 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.75 HD21 ' HG3' ' A' ' 12' ' ' LYS . 3.6 mm? . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.634 0.254 . . . . 0.0 110.334 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.731 ' HG2' ' CD1' ' A' ' 10' ' ' TRP . 14.5 Cg_endo -58.98 147.91 87.64 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.599 2.199 . . . . 0.0 110.789 170.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 7' ' ' PRO . 77.9 Cg_exo -50.14 100.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.526 2.817 . . . . 0.0 113.309 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 24' ' ' ASN . . . 125.91 -18.76 6.61 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.491 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.731 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 95.5 m95 -96.25 166.93 11.49 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -174.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -162.2 155.21 20.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.75 ' HG3' HD21 ' A' ' 6' ' ' LEU . 37.2 mtmt -98.95 70.65 1.84 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.434 ' HG2' ' OE1' ' A' ' 11' ' ' GLU . 14.4 mtm180 -83.54 159.06 21.75 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.901 -172.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.5 p -108.56 158.29 17.7 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.707 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -108.6 -174.25 2.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.179 0.514 . . . . 0.0 110.794 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.3 p -77.38 -4.67 46.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.71 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -94.41 -30.91 14.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.504 0.669 . . . . 0.0 109.694 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.02 15.84 8.88 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -96.75 164.72 12.45 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.274 -0.463 . . . . 0.0 110.759 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.19 132.79 62.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.118 0.485 . . . . 0.0 110.892 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.33 156.45 46.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.72 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.63 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 86.3 m-85 -97.81 121.81 40.17 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.81 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 4.8 p -106.77 136.34 42.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.188 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.556 ' HB3' ' H ' ' A' ' 29' ' ' ILE . 26.0 t-20 -108.79 121.66 45.53 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -82.1 -26.28 33.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.727 0.298 . . . . 0.0 111.302 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.27 -57.08 9.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.392 -174.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.741 HG23 HG12 ' A' ' 29' ' ' ILE . 3.7 t -119.0 11.55 12.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.168 0.508 . . . . 0.0 111.48 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 20.3 mmt180 60.96 63.42 1.27 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.942 175.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.741 HG12 HG23 ' A' ' 27' ' ' THR . 49.1 mm -111.71 121.16 63.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.312 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.7 m -102.08 102.19 12.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -119.54 142.51 48.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.392 0.615 . . . . 0.0 110.973 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -93.74 -24.15 17.93 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.877 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.1 147.87 34.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.33 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 9.8 t0 -76.35 121.0 84.1 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 34' ' ' ASP . 18.5 Cg_exo . . . . . 0 C--N 1.344 0.324 0 C-N-CA 123.022 2.481 . . . . 0.0 112.112 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.613 ' HG ' ' HA ' ' A' ' 11' ' ' GLU . 4.5 mm? . . . . . 0 C--O 1.235 0.316 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.821 ' HG3' ' HB2' ' A' ' 35' ' ' PRO . 12.0 Cg_endo -53.9 127.83 27.21 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 121.814 1.676 . . . . 0.0 110.567 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -34.4 98.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 124.576 3.518 . . . . 0.0 114.445 -169.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.67 -19.83 6.17 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.222 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.712 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 94.4 m95 -94.6 164.02 13.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.83 0.348 . . . . 0.0 111.53 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.613 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 9.7 tp10 -162.7 153.7 17.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.878 171.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.613 ' HG2' ' CE2' ' A' ' 22' ' ' PHE . 52.3 mtpt -93.33 95.15 9.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.423 0.63 . . . . 0.0 110.399 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 6.7 mtt180 -89.44 166.13 13.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.211 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.8 OUTLIER -120.63 143.44 48.68 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.958 176.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -94.94 -168.94 1.9 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.59 0.233 . . . . 0.0 110.736 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.8 p -67.72 -20.57 65.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.888 0.375 . . . . 0.0 111.588 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -89.7 -27.84 19.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.557 0.694 . . . . 0.0 109.614 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.54 12.58 18.87 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.355 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 14' ' ' THR . 8.2 mtt180 -85.11 153.58 22.6 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 15.7 m -97.95 123.96 50.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.417 0.627 . . . . 0.0 111.347 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -123.58 146.74 47.92 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.122 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.613 ' CE2' ' HG2' ' A' ' 12' ' ' LYS . 62.9 m-85 -95.61 117.44 30.46 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.098 0.475 . . . . 0.0 110.213 -173.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 7.1 p -103.61 131.57 51.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.803 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.665 ' HB3' ' H ' ' A' ' 29' ' ' ILE . 26.8 t-20 -103.56 116.53 32.54 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -79.19 -19.23 51.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.636 0.255 . . . . 0.0 110.985 -174.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -69.43 -62.84 1.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.294 -175.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.678 HG23 HG12 ' A' ' 29' ' ' ILE . 14.4 t -117.93 15.01 14.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.681 0.753 . . . . 0.0 111.121 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 11.4 mmt180 60.38 61.14 1.84 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.563 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.678 HG12 HG23 ' A' ' 27' ' ' THR . 49.5 mm -104.01 117.08 48.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.899 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.0 m -96.05 98.32 10.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -101.71 161.9 13.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.738 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -118.01 -7.58 10.84 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.527 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.73 148.09 34.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.923 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 33.2 t70 -68.2 121.82 81.71 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.096 -173.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.821 ' HB2' ' HG3' ' A' ' 7' ' ' PRO . 6.9 Cg_exo . . . . . 0 N--CA 1.463 -0.313 0 C-N-CA 123.585 2.856 . . . . 0.0 112.239 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.48 HD21 ' HG3' ' A' ' 12' ' ' LYS . 4.1 mm? . . . . . 0 N--CA 1.454 -0.249 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.626 ' HG2' ' CD1' ' A' ' 10' ' ' TRP . 18.3 Cg_endo -59.7 134.6 58.57 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.961 1.774 . . . . 0.0 110.339 174.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.69 110.75 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.518 2.812 . . . . 0.0 113.068 -176.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.86 -29.1 5.92 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.881 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.626 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 97.7 m95 -98.18 159.29 15.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.031 0.443 . . . . 0.0 112.109 -174.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -161.31 149.1 15.26 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.049 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.48 ' HG3' HD21 ' A' ' 6' ' ' LEU . 55.4 mtpt -94.87 105.68 17.62 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.846 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -120.39 152.13 38.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.907 -172.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 40.0 p -90.08 148.7 22.87 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.026 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -96.32 -166.44 1.42 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.683 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.2 p -68.29 -17.08 64.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.763 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -90.86 -42.36 10.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.95 18.84 2.82 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.234 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 14' ' ' THR . 15.5 mtt180 -95.37 149.76 21.02 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.2 m -96.22 109.14 22.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.653 0.739 . . . . 0.0 111.258 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -101.81 174.91 5.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.289 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.432 ' CE1' ' HG2' ' A' ' 12' ' ' LYS . 69.4 m-85 -112.5 109.31 18.81 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.369 0.604 . . . . 0.0 109.818 -177.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 8.2 p -94.76 137.96 21.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.33 -176.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 27.1 t-20 -105.91 115.01 29.5 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 172.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -75.94 -21.03 57.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.83 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -73.62 -65.63 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.92 0.39 . . . . 0.0 111.221 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.808 HG23 HG12 ' A' ' 29' ' ' ILE . 6.4 t -102.03 4.55 39.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.263 0.554 . . . . 0.0 111.262 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 19.2 mmt180 59.21 63.78 1.52 Allowed 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.95 178.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.808 HG12 HG23 ' A' ' 27' ' ' THR . 45.5 mm -113.33 127.28 70.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.889 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -101.45 100.37 10.81 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.611 ' HG3' HG22 ' A' ' 29' ' ' ILE . 17.7 mt-30 -111.59 155.24 23.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.961 0.41 . . . . 0.0 110.89 -177.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -103.23 -9.62 19.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.684 0.754 . . . . 0.0 109.174 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -80.38 148.18 30.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.889 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.502 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 9.1 t70 -80.74 122.92 82.67 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.461 -176.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 34' ' ' ASP . 5.6 Cg_exo . . . . . 0 C--N 1.344 0.332 0 C-N-CA 123.645 2.897 . . . . 0.0 113.599 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.45 70.05 0.69 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.261 0.553 . . . . 0.0 110.683 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -80.01 21.9 0.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.318 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.5 163.94 18.87 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.021 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.45 168.35 24.98 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.233 2.622 . . . . 0.0 111.474 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.848 HD21 ' HG3' ' A' ' 12' ' ' LYS . 4.2 mm? -73.95 138.94 76.22 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.331 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.921 ' HD3' ' HD3' ' A' ' 36' ' ' ARG . 5.9 Cg_exo -53.49 142.22 59.83 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.916 2.411 . . . . 0.0 110.809 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -40.91 97.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.041 3.161 . . . . 0.0 114.261 -172.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.61 -27.34 4.97 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.345 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.608 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 95.7 m95 -85.55 163.49 18.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.472 0.177 . . . . 0.0 111.447 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.586 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 10.1 tp10 -163.61 152.18 13.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.096 173.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.848 ' HG3' HD21 ' A' ' 6' ' ' LEU . 30.0 mtmt -91.79 100.92 13.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.355 0.598 . . . . 0.0 109.594 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -111.22 163.68 13.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.146 -173.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.3 p -114.39 147.73 38.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.124 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -94.94 -169.38 1.99 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.622 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.4 p -71.31 -24.87 62.21 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.409 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.91 -25.8 14.88 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.045 -171.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.42 14.79 2.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.054 -1.069 . . . . 0.0 113.003 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -87.28 153.73 21.25 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.862 -0.199 . . . . 0.0 110.483 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.8 m -104.22 121.98 56.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.19 0.519 . . . . 0.0 110.169 174.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.457 ' CD1' HG23 ' A' ' 30' ' ' THR . 43.2 p90 -124.69 171.64 9.91 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.806 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.531 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 80.2 m-85 -117.23 118.16 31.55 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.779 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 9.8 p -96.83 131.73 42.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.652 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -101.1 115.86 31.47 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -66.95 -32.73 74.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.82 -178.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -66.46 -61.2 2.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.652 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.544 ' HB ' HG12 ' A' ' 29' ' ' ILE . 11.2 p -87.28 -13.87 42.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.767 -176.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.422 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 16.5 mmt180 66.13 33.29 7.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.423 -176.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.544 HG12 ' HB ' ' A' ' 27' ' ' THR . 41.8 mm -94.47 134.58 31.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.879 -176.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.457 HG23 ' CD1' ' A' ' 21' ' ' TYR . 69.6 m -98.11 96.25 7.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.011 175.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -101.56 158.69 15.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.988 0.423 . . . . 0.0 110.031 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -111.99 -29.29 7.69 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.126 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.82 140.02 56.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.05 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.489 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 8.9 t0 -80.01 120.69 80.59 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.755 -176.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 34' ' ' ASP . 4.4 Cg_exo -76.62 -21.71 12.69 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.35 2.7 . . . . 0.0 112.376 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.921 ' HD3' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -91.81 42.68 1.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.359 0.6 . . . . 0.0 110.978 -178.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 C--O 1.247 0.966 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.896 -179.431 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.83 124.37 48.22 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.9 mtp -101.33 137.47 39.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.109 0.48 . . . . 0.0 111.454 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.0 -130.84 7.97 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.364 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.18 -157.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 124.168 3.245 . . . . 0.0 112.471 173.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.59 HD21 ' HG3' ' A' ' 12' ' ' LYS . 4.6 mm? -56.72 164.27 2.26 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.621 172.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.629 ' HG2' ' HB2' ' A' ' 35' ' ' PRO . 11.6 Cg_exo -62.4 151.09 84.82 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.861 1.707 . . . . 0.0 109.82 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -39.68 98.28 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.801 3.001 . . . . 0.0 114.473 -174.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.96 -16.75 27.77 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.447 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.587 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 95.1 m95 -87.46 168.48 13.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.141 0.496 . . . . 0.0 112.28 -174.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.544 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 65.1 tt0 -162.07 151.86 16.41 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.433 175.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.59 ' HG3' HD21 ' A' ' 6' ' ' LEU . 53.8 mtpt -95.36 100.73 12.46 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -106.56 161.04 14.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.821 -172.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 p -104.47 138.39 40.92 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.763 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 16' ' ' SER . 17.3 t70 -97.29 -176.5 3.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.288 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.486 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 35.5 p -57.66 -56.98 14.88 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.515 0.726 . . . . 0.0 112.57 -173.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -84.24 20.28 1.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.783 0.325 . . . . 0.0 111.649 -174.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.4 9.43 81.75 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.703 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -65.83 161.88 20.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.2 m -124.89 132.24 71.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 120.938 0.399 . . . . 0.0 110.099 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -139.93 174.16 10.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.008 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.563 ' CE2' ' HG2' ' A' ' 12' ' ' LYS . 58.9 m-85 -115.78 121.99 44.1 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.892 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 3.1 p -110.45 142.73 22.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.679 -175.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -106.07 111.79 24.56 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 11' ' ' GLU . 27.9 m80 -65.07 -36.53 84.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.284 -173.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -62.13 -62.59 1.66 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.936 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.823 HG23 HG12 ' A' ' 29' ' ' ILE . 5.3 t -104.26 8.14 36.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.08 0.467 . . . . 0.0 111.677 -176.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 60.04 45.57 11.84 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.435 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.823 HG12 HG23 ' A' ' 27' ' ' THR . 44.0 mm -96.68 134.31 34.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.186 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.6 m -108.35 122.79 47.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.663 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -127.13 154.15 45.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.426 0.632 . . . . 0.0 110.556 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -99.61 -34.3 10.27 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.412 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -88.18 152.17 22.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.883 0.373 . . . . 0.0 111.4 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -70.71 121.77 84.73 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.018 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.629 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 17.3 Cg_exo -70.92 -18.33 31.64 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.563 2.842 . . . . 0.0 113.447 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -93.19 66.68 4.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.39 0.614 . . . . 0.0 112.05 -173.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.248 1.023 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.633 174.674 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 3' ' ' MET . . . -80.33 102.58 9.65 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 61.7 mtt 67.04 -84.6 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 123.726 0.641 . . . . 0.0 110.776 -173.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.14 106.09 3.08 Favored Glycine 0 C--N 1.303 -1.26 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.671 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -53.02 144.58 45.29 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.579 2.853 . . . . 0.0 112.888 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.678 ' HG ' ' HA ' ' A' ' 11' ' ' GLU . 3.1 mm? -82.34 160.04 63.24 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.117 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.695 ' HG3' ' HB2' ' A' ' 35' ' ' PRO . 6.0 Cg_endo -54.02 143.95 59.48 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.26 1.974 . . . . 0.0 110.82 172.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 7' ' ' PRO . 71.9 Cg_exo -49.45 106.54 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.405 2.737 . . . . 0.0 112.874 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.9 -21.19 9.04 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.109 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.622 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 97.6 m95 -98.7 166.22 11.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.695 0.284 . . . . 0.0 111.35 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.678 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 10.0 tp10 -167.7 155.14 8.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.181 169.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.585 ' HG3' HD21 ' A' ' 6' ' ' LEU . 38.2 mtpt -93.33 95.06 9.09 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.419 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.582 ' HD3' HG11 ' A' ' 23' ' ' VAL . 3.5 mpt_? -98.56 -175.6 3.13 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.472 174.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 16.5 p -129.66 131.31 46.36 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.76 -171.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.428 ' OD1' ' HD2' ' A' ' 21' ' ' TYR . 1.1 m-20 -79.65 178.19 8.34 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.108 0.48 . . . . 0.0 109.709 173.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.0 p -74.63 -3.27 30.22 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.764 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.413 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 10.9 p30 -102.06 -1.16 32.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.989 0.423 . . . . 0.0 110.485 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.72 -3.17 67.71 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.068 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 14' ' ' THR . 2.6 mtt180 -68.69 160.71 29.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.906 0.384 . . . . 0.0 111.149 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 12.1 m -120.08 108.26 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.607 174.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.428 ' HD2' ' OD1' ' A' ' 15' ' ' ASP . 25.2 p90 -104.18 157.47 17.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.227 0.537 . . . . 0.0 110.964 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.464 ' CE2' ' HG2' ' A' ' 12' ' ' LYS . 49.6 m-85 -101.97 110.81 22.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.474 -177.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.582 HG11 ' HD3' ' A' ' 13' ' ' ARG . 7.6 p -105.56 124.22 60.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.717 -173.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -93.33 120.14 33.28 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -77.19 -20.88 54.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.517 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -76.15 -50.71 13.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.161 0.505 . . . . 0.0 110.724 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.6 p -104.87 -3.13 23.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.334 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.52 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 4.5 mpt_? 60.58 40.1 17.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.785 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.0 mm -96.94 118.04 42.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.477 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -93.74 95.15 8.97 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.679 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.416 ' OE1' ' HB2' ' A' ' 33' ' ' GLU . 4.7 tt0 -99.64 151.79 20.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.633 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -103.76 -14.3 16.12 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.14 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.416 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 13.0 mm-40 -87.71 140.93 29.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.129 -178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.494 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 23.5 t70 -78.66 117.83 68.83 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.746 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.695 ' HB2' ' HG3' ' A' ' 7' ' ' PRO . 5.7 Cg_exo -81.44 -11.29 11.86 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.568 2.845 . . . . 0.0 112.834 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -81.97 48.29 1.21 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.979 -172.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.252 1.207 0 CA-C-O 119.067 -0.492 . . . . 0.0 110.534 179.453 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.65 12.96 19.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.287 0.565 . . . . 0.0 110.908 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.8 mtp -102.0 150.13 23.54 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.797 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.28 138.96 6.05 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.344 -0.931 . . . . 0.0 112.28 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -45.75 150.7 1.51 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 124.134 3.223 . . . . 0.0 112.996 172.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.884 HD21 ' HG3' ' A' ' 12' ' ' LYS . 3.6 mm? -67.26 149.46 98.42 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.447 176.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.772 ' HG3' ' HB2' ' A' ' 35' ' ' PRO . 3.1 Cg_endo -49.17 134.4 30.32 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.556 2.171 . . . . 0.0 110.457 176.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -42.66 98.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.716 2.944 . . . . 0.0 113.408 -171.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 24' ' ' ASN . . . 128.42 -24.51 4.96 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.117 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.631 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 97.3 m95 -91.11 165.27 13.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.799 0.333 . . . . 0.0 111.535 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.563 ' HB3' HG12 ' A' ' 23' ' ' VAL . 71.9 tt0 -162.19 151.0 15.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.625 175.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.884 ' HG3' HD21 ' A' ' 6' ' ' LEU . 34.0 mtmt -97.7 98.08 9.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.438 0.637 . . . . 0.0 109.334 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.411 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 9.9 mtm180 -105.48 160.28 15.27 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.483 -172.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.1 p -95.05 140.93 29.31 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.474 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HA ' ' HE2' ' A' ' 21' ' ' TYR . 30.5 t70 -93.4 175.54 6.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.036 -177.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.425 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 30.0 p -65.41 -33.84 76.9 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.63 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -92.13 13.12 19.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.537 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.44 -1.06 89.16 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.251 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -72.73 -174.72 1.49 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.942 0.401 . . . . 0.0 111.008 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.8 m -133.31 124.41 48.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.144 0.497 . . . . 0.0 110.521 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.444 ' HE2' ' HA ' ' A' ' 15' ' ' ASP . 41.5 p90 -119.15 167.07 12.17 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.63 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 79.0 m-85 -110.87 113.36 25.87 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 6.1 p -99.9 141.33 17.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.578 -173.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB3' ' H ' ' A' ' 29' ' ' ILE . 21.7 t-20 -112.35 117.32 32.13 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -80.23 -19.57 46.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.484 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -81.78 -63.5 1.38 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.546 -175.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.704 HG23 HG12 ' A' ' 29' ' ' ILE . 13.1 t -95.32 -2.37 49.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.2 0.524 . . . . 0.0 110.974 -176.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 23.6 mmt180 63.42 67.88 0.63 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.943 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.704 HG12 HG23 ' A' ' 27' ' ' THR . 38.1 mm -122.96 130.98 74.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.201 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.3 m -109.16 95.22 5.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.104 0.478 . . . . 0.0 110.219 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.418 ' HG3' HG22 ' A' ' 29' ' ' ILE . 18.1 mt-30 -102.13 172.8 6.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.309 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -120.84 6.18 10.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.964 0.412 . . . . 0.0 110.193 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -99.56 139.64 34.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.107 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 10.7 t0 -83.56 116.7 65.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.872 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.772 ' HB2' ' HG3' ' A' ' 7' ' ' PRO . 6.5 Cg_exo -78.54 -11.86 15.5 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.512 2.808 . . . . 0.0 114.295 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.649 ' HD3' HD13 ' A' ' 6' ' ' LEU . 42.6 mtm180 -81.99 53.71 2.28 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -168.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 C--O 1.253 1.263 0 CA-C-O 118.14 -0.933 . . . . 0.0 110.119 174.839 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 112.239 -0.344 . . . . 0.0 112.239 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.52 38.49 29.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.015 0.436 . . . . 0.0 111.271 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.5 mtt -147.59 151.68 36.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.544 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.2 -76.27 1.18 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 172.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -78.97 178.21 7.81 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.238 2.625 . . . . 0.0 111.799 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.808 HD21 ' HG3' ' A' ' 12' ' ' LYS . 4.5 mm? -78.84 166.77 40.09 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.75 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.546 ' HD2' ' HB2' ' A' ' 10' ' ' TRP . 16.6 Cg_exo -66.01 149.05 86.31 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.576 2.184 . . . . 0.0 109.983 175.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -54.78 100.61 0.07 OUTLIER 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.349 2.7 . . . . 0.0 113.312 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.503 ' HA3' ' ND2' ' A' ' 26' ' ' ASN . . . 124.56 -19.68 7.04 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.693 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.717 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 97.1 m95 -99.98 162.63 12.87 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.532 0.333 . . . . 0.0 110.769 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 9.6 tp10 -168.09 156.64 9.0 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.808 ' HG3' HD21 ' A' ' 6' ' ' LEU . 23.7 mtmm -95.81 88.23 4.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -92.78 152.64 19.35 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.816 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.1 p -94.32 131.32 40.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.67 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 16' ' ' SER . 24.1 t0 -86.03 -178.3 6.51 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.244 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.488 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 57.1 p -58.73 -50.5 73.66 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.039 -173.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -93.9 28.78 2.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.759 -172.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.13 -6.19 80.27 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.532 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.05 167.07 1.79 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.944 0.402 . . . . 0.0 111.33 174.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.9 m -129.08 137.67 56.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.419 ' CD1' HG23 ' A' ' 30' ' ' THR . 52.0 p90 -140.02 161.3 37.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.127 0.489 . . . . 0.0 110.298 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 85.3 m-85 -103.41 114.18 28.25 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.684 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.717 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 9.9 p -97.28 136.13 29.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.564 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 53.7 t-20 -114.45 97.88 6.57 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 171.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -76.77 -11.7 59.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.113 0.482 . . . . 0.0 111.479 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.503 ' ND2' ' HA3' ' A' ' 9' ' ' GLY . 72.6 m-20 -66.02 -62.71 1.34 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.838 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.0 p -96.06 2.35 53.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.665 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 64.57 40.75 5.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.008 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.1 mm -105.35 128.12 59.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.198 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.419 HG23 ' CD1' ' A' ' 21' ' ' TYR . 40.5 m -96.48 109.3 21.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.897 173.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -111.2 161.35 16.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.135 0.493 . . . . 0.0 110.239 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -116.76 -22.44 8.58 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.519 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -85.82 159.1 19.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.922 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 26.6 t70 -77.46 126.63 84.47 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.096 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.487 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 17.4 Cg_exo -70.38 -27.22 23.76 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.772 2.981 . . . . 0.0 113.059 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.554 HH21 HD22 ' A' ' 6' ' ' LEU . 11.0 mtt85 -79.77 -15.73 56.91 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.684 0.278 . . . . 0.0 110.709 -176.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.5 p . . . . . 0 C--O 1.249 1.046 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.072 177.898 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 112.246 -0.342 . . . . 0.0 112.246 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.18 88.83 6.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.185 0.517 . . . . 0.0 110.018 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.3 mtt -91.05 17.27 8.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.147 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.97 136.85 46.06 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.832 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.35 171.0 18.88 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.066 2.511 . . . . 0.0 112.092 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.75 HD21 ' HG3' ' A' ' 12' ' ' LYS . 3.6 mm? -100.46 155.5 36.31 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.334 177.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.731 ' HG2' ' CD1' ' A' ' 10' ' ' TRP . 14.5 Cg_endo -58.98 147.91 87.64 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.599 2.199 . . . . 0.0 110.789 170.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 7' ' ' PRO . 77.9 Cg_exo -50.14 100.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.526 2.817 . . . . 0.0 113.309 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 24' ' ' ASN . . . 125.91 -18.76 6.61 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.491 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.731 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 95.5 m95 -96.25 166.93 11.49 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -174.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -162.2 155.21 20.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.75 ' HG3' HD21 ' A' ' 6' ' ' LEU . 37.2 mtmt -98.95 70.65 1.84 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.434 ' HG2' ' OE1' ' A' ' 11' ' ' GLU . 14.4 mtm180 -83.54 159.06 21.75 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.901 -172.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.5 p -108.56 158.29 17.7 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.707 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -108.6 -174.25 2.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.179 0.514 . . . . 0.0 110.794 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.3 p -77.38 -4.67 46.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.71 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -94.41 -30.91 14.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.504 0.669 . . . . 0.0 109.694 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.02 15.84 8.88 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -96.75 164.72 12.45 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.274 -0.463 . . . . 0.0 110.759 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.19 132.79 62.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.118 0.485 . . . . 0.0 110.892 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.33 156.45 46.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.72 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.63 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 86.3 m-85 -97.81 121.81 40.17 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.81 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 4.8 p -106.77 136.34 42.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.188 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.556 ' HB3' ' H ' ' A' ' 29' ' ' ILE . 26.0 t-20 -108.79 121.66 45.53 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -82.1 -26.28 33.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.727 0.298 . . . . 0.0 111.302 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.27 -57.08 9.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.392 -174.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.741 HG23 HG12 ' A' ' 29' ' ' ILE . 3.7 t -119.0 11.55 12.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.168 0.508 . . . . 0.0 111.48 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 20.3 mmt180 60.96 63.42 1.27 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.942 175.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.741 HG12 HG23 ' A' ' 27' ' ' THR . 49.1 mm -111.71 121.16 63.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.312 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.7 m -102.08 102.19 12.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -119.54 142.51 48.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.392 0.615 . . . . 0.0 110.973 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -93.74 -24.15 17.93 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.877 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.1 147.87 34.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.33 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 9.8 t0 -76.35 121.0 84.1 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 34' ' ' ASP . 18.5 Cg_exo -65.87 -22.7 55.9 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.022 2.481 . . . . 0.0 112.112 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.683 ' HD3' HD13 ' A' ' 6' ' ' LEU . 47.4 mtm180 -96.43 -5.42 39.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.349 -170.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--O 1.244 0.768 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.056 -179.966 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.17 19.23 10.76 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.107 0.563 . . . . 0.0 112.124 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.8 mtp -88.22 89.26 7.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.18 145.11 9.25 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.456 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -80.12 131.08 8.62 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.527 2.151 . . . . 0.0 112.768 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.613 ' HG ' ' HA ' ' A' ' 11' ' ' GLU . 4.5 mm? -64.39 150.49 93.06 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 168.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.821 ' HG3' ' HB2' ' A' ' 35' ' ' PRO . 12.0 Cg_endo -53.9 127.83 27.21 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 121.814 1.676 . . . . 0.0 110.567 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -34.4 98.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 124.576 3.518 . . . . 0.0 114.445 -169.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.67 -19.83 6.17 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.222 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.712 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 94.4 m95 -94.6 164.02 13.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.83 0.348 . . . . 0.0 111.53 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.613 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 9.7 tp10 -162.7 153.7 17.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.878 171.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.613 ' HG2' ' CE2' ' A' ' 22' ' ' PHE . 52.3 mtpt -93.33 95.15 9.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.423 0.63 . . . . 0.0 110.399 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 6.7 mtt180 -89.44 166.13 13.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.211 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.8 OUTLIER -120.63 143.44 48.68 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.958 176.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -94.94 -168.94 1.9 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.59 0.233 . . . . 0.0 110.736 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.8 p -67.72 -20.57 65.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.888 0.375 . . . . 0.0 111.588 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -89.7 -27.84 19.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.557 0.694 . . . . 0.0 109.614 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.54 12.58 18.87 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.355 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 14' ' ' THR . 8.2 mtt180 -85.11 153.58 22.6 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 15.7 m -97.95 123.96 50.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.417 0.627 . . . . 0.0 111.347 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -123.58 146.74 47.92 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.122 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.613 ' CE2' ' HG2' ' A' ' 12' ' ' LYS . 62.9 m-85 -95.61 117.44 30.46 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.098 0.475 . . . . 0.0 110.213 -173.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 7.1 p -103.61 131.57 51.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.803 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.665 ' HB3' ' H ' ' A' ' 29' ' ' ILE . 26.8 t-20 -103.56 116.53 32.54 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -79.19 -19.23 51.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.636 0.255 . . . . 0.0 110.985 -174.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -69.43 -62.84 1.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.294 -175.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.678 HG23 HG12 ' A' ' 29' ' ' ILE . 14.4 t -117.93 15.01 14.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.681 0.753 . . . . 0.0 111.121 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 11.4 mmt180 60.38 61.14 1.84 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.563 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.678 HG12 HG23 ' A' ' 27' ' ' THR . 49.5 mm -104.01 117.08 48.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.899 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.0 m -96.05 98.32 10.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -101.71 161.9 13.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.738 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -118.01 -7.58 10.84 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.527 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.73 148.09 34.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.923 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 33.2 t70 -68.2 121.82 81.71 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.096 -173.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.821 ' HB2' ' HG3' ' A' ' 7' ' ' PRO . 6.9 Cg_exo -77.27 -17.73 14.65 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.585 2.856 . . . . 0.0 112.239 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.534 ' HG3' ' HD3' ' A' ' 7' ' ' PRO . 8.8 mtp180 -68.09 -73.18 0.15 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.461 -173.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.845 -175.089 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.78 130.63 2.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.329 . . . . 0.0 110.698 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.8 mtm -69.8 143.04 53.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.021 175.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.53 124.49 0.73 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.656 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -51.86 134.58 48.62 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.635 2.89 . . . . 0.0 112.568 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.48 HD21 ' HG3' ' A' ' 12' ' ' LYS . 4.1 mm? -68.42 156.91 89.4 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.77 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.626 ' HG2' ' CD1' ' A' ' 10' ' ' TRP . 18.3 Cg_endo -59.7 134.6 58.57 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.961 1.774 . . . . 0.0 110.339 174.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.69 110.75 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.518 2.812 . . . . 0.0 113.068 -176.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.86 -29.1 5.92 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.881 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.626 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 97.7 m95 -98.18 159.29 15.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.031 0.443 . . . . 0.0 112.109 -174.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -161.31 149.1 15.26 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.049 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.48 ' HG3' HD21 ' A' ' 6' ' ' LEU . 55.4 mtpt -94.87 105.68 17.62 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.846 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -120.39 152.13 38.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.907 -172.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 40.0 p -90.08 148.7 22.87 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.026 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -96.32 -166.44 1.42 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.683 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.2 p -68.29 -17.08 64.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.763 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -90.86 -42.36 10.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.95 18.84 2.82 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.234 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 14' ' ' THR . 15.5 mtt180 -95.37 149.76 21.02 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.2 m -96.22 109.14 22.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.653 0.739 . . . . 0.0 111.258 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -101.81 174.91 5.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.289 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.432 ' CE1' ' HG2' ' A' ' 12' ' ' LYS . 69.4 m-85 -112.5 109.31 18.81 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.369 0.604 . . . . 0.0 109.818 -177.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 8.2 p -94.76 137.96 21.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.33 -176.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 27.1 t-20 -105.91 115.01 29.5 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 172.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -75.94 -21.03 57.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.83 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -73.62 -65.63 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.92 0.39 . . . . 0.0 111.221 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.808 HG23 HG12 ' A' ' 29' ' ' ILE . 6.4 t -102.03 4.55 39.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.263 0.554 . . . . 0.0 111.262 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 19.2 mmt180 59.21 63.78 1.52 Allowed 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.95 178.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.808 HG12 HG23 ' A' ' 27' ' ' THR . 45.5 mm -113.33 127.28 70.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.889 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -101.45 100.37 10.81 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.611 ' HG3' HG22 ' A' ' 29' ' ' ILE . 17.7 mt-30 -111.59 155.24 23.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.961 0.41 . . . . 0.0 110.89 -177.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -103.23 -9.62 19.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.684 0.754 . . . . 0.0 109.174 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -80.38 148.18 30.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.889 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.502 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 9.1 t70 -80.74 122.92 82.67 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.461 -176.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 34' ' ' ASP . 5.6 Cg_exo -84.54 -8.7 9.42 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.645 2.897 . . . . 0.0 113.599 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.503 ' HG3' ' HD3' ' A' ' 7' ' ' PRO . 34.9 mtp85 -88.14 51.97 2.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.336 0.589 . . . . 0.0 111.886 -174.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.328 177.315 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.848 HD21 ' HG3' ' A' ' 12' ' ' LYS . 4.2 mm? . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 120.79 0.329 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HG2' ' CD1' ' A' ' 10' ' ' TRP . 5.9 Cg_exo -53.49 142.22 59.83 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.916 2.411 . . . . 0.0 110.809 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -40.91 97.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.041 3.161 . . . . 0.0 114.261 -172.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.61 -27.34 4.97 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.345 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.608 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 95.7 m95 -85.55 163.49 18.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.472 0.177 . . . . 0.0 111.447 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.586 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 10.1 tp10 -163.61 152.18 13.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.096 173.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.848 ' HG3' HD21 ' A' ' 6' ' ' LEU . 30.0 mtmt -91.79 100.92 13.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.355 0.598 . . . . 0.0 109.594 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -111.22 163.68 13.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.146 -173.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.3 p -114.39 147.73 38.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.124 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -94.94 -169.38 1.99 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.622 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.4 p -71.31 -24.87 62.21 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.409 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.91 -25.8 14.88 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.045 -171.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.42 14.79 2.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.054 -1.069 . . . . 0.0 113.003 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -87.28 153.73 21.25 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.862 -0.199 . . . . 0.0 110.483 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.8 m -104.22 121.98 56.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.19 0.519 . . . . 0.0 110.169 174.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.457 ' CD1' HG23 ' A' ' 30' ' ' THR . 43.2 p90 -124.69 171.64 9.91 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.806 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.531 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 80.2 m-85 -117.23 118.16 31.55 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.779 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 9.8 p -96.83 131.73 42.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.652 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -101.1 115.86 31.47 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -66.95 -32.73 74.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.82 -178.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -66.46 -61.2 2.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.652 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.544 ' HB ' HG12 ' A' ' 29' ' ' ILE . 11.2 p -87.28 -13.87 42.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.767 -176.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.422 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 16.5 mmt180 66.13 33.29 7.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.423 -176.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.544 HG12 ' HB ' ' A' ' 27' ' ' THR . 41.8 mm -94.47 134.58 31.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.879 -176.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.457 HG23 ' CD1' ' A' ' 21' ' ' TYR . 69.6 m -98.11 96.25 7.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.011 175.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -101.56 158.69 15.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.988 0.423 . . . . 0.0 110.031 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -111.99 -29.29 7.69 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.126 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.82 140.02 56.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.05 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.489 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 8.9 t0 -80.01 120.69 80.59 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.755 -176.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 34' ' ' ASP . 4.4 Cg_exo . . . . . 0 N--CA 1.46 -0.486 0 C-N-CA 123.35 2.7 . . . . 0.0 112.376 177.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.59 HD21 ' HG3' ' A' ' 12' ' ' LYS . 4.6 mm? . . . . . 0 C--O 1.235 0.337 0 CA-C-O 120.608 0.242 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.629 ' HG2' ' HB2' ' A' ' 35' ' ' PRO . 11.6 Cg_exo -62.4 151.09 84.82 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.861 1.707 . . . . 0.0 109.82 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -39.68 98.28 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.801 3.001 . . . . 0.0 114.473 -174.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.96 -16.75 27.77 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.447 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.587 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 95.1 m95 -87.46 168.48 13.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.141 0.496 . . . . 0.0 112.28 -174.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.544 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 65.1 tt0 -162.07 151.86 16.41 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.433 175.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.59 ' HG3' HD21 ' A' ' 6' ' ' LEU . 53.8 mtpt -95.36 100.73 12.46 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -106.56 161.04 14.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.821 -172.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 p -104.47 138.39 40.92 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.763 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 16' ' ' SER . 17.3 t70 -97.29 -176.5 3.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.288 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.486 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 35.5 p -57.66 -56.98 14.88 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.515 0.726 . . . . 0.0 112.57 -173.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -84.24 20.28 1.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.783 0.325 . . . . 0.0 111.649 -174.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.4 9.43 81.75 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.703 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -65.83 161.88 20.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.2 m -124.89 132.24 71.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 120.938 0.399 . . . . 0.0 110.099 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -139.93 174.16 10.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.008 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.563 ' CE2' ' HG2' ' A' ' 12' ' ' LYS . 58.9 m-85 -115.78 121.99 44.1 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.892 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 3.1 p -110.45 142.73 22.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.679 -175.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -106.07 111.79 24.56 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 11' ' ' GLU . 27.9 m80 -65.07 -36.53 84.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.284 -173.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -62.13 -62.59 1.66 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.936 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.823 HG23 HG12 ' A' ' 29' ' ' ILE . 5.3 t -104.26 8.14 36.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.08 0.467 . . . . 0.0 111.677 -176.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 60.04 45.57 11.84 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.435 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.823 HG12 HG23 ' A' ' 27' ' ' THR . 44.0 mm -96.68 134.31 34.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.186 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.6 m -108.35 122.79 47.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.663 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -127.13 154.15 45.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.426 0.632 . . . . 0.0 110.556 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -99.61 -34.3 10.27 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.412 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -88.18 152.17 22.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.883 0.373 . . . . 0.0 111.4 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -70.71 121.77 84.73 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.018 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.629 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 17.3 Cg_exo . . . . . 0 C--N 1.342 0.22 0 C-N-CA 123.563 2.842 . . . . 0.0 113.447 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.678 ' HG ' ' HA ' ' A' ' 11' ' ' GLU . 3.1 mm? . . . . . 0 C--O 1.231 0.105 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.695 ' HG3' ' HB2' ' A' ' 35' ' ' PRO . 6.0 Cg_endo -54.02 143.95 59.48 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.26 1.974 . . . . 0.0 110.82 172.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 7' ' ' PRO . 71.9 Cg_exo -49.45 106.54 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.405 2.737 . . . . 0.0 112.874 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.9 -21.19 9.04 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.109 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.622 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 97.6 m95 -98.7 166.22 11.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.695 0.284 . . . . 0.0 111.35 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.678 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 10.0 tp10 -167.7 155.14 8.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.181 169.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.585 ' HG3' HD21 ' A' ' 6' ' ' LEU . 38.2 mtpt -93.33 95.06 9.09 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.419 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.582 ' HD3' HG11 ' A' ' 23' ' ' VAL . 3.5 mpt_? -98.56 -175.6 3.13 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.472 174.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 16.5 p -129.66 131.31 46.36 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.76 -171.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.428 ' OD1' ' HD2' ' A' ' 21' ' ' TYR . 1.1 m-20 -79.65 178.19 8.34 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.108 0.48 . . . . 0.0 109.709 173.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.0 p -74.63 -3.27 30.22 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.764 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.413 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 10.9 p30 -102.06 -1.16 32.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.989 0.423 . . . . 0.0 110.485 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.72 -3.17 67.71 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.068 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 14' ' ' THR . 2.6 mtt180 -68.69 160.71 29.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.906 0.384 . . . . 0.0 111.149 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 12.1 m -120.08 108.26 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.607 174.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.428 ' HD2' ' OD1' ' A' ' 15' ' ' ASP . 25.2 p90 -104.18 157.47 17.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.227 0.537 . . . . 0.0 110.964 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.464 ' CE2' ' HG2' ' A' ' 12' ' ' LYS . 49.6 m-85 -101.97 110.81 22.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.474 -177.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.582 HG11 ' HD3' ' A' ' 13' ' ' ARG . 7.6 p -105.56 124.22 60.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.717 -173.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -93.33 120.14 33.28 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -77.19 -20.88 54.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.517 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -76.15 -50.71 13.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.161 0.505 . . . . 0.0 110.724 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.6 p -104.87 -3.13 23.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.334 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.52 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 4.5 mpt_? 60.58 40.1 17.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.785 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.0 mm -96.94 118.04 42.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.477 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -93.74 95.15 8.97 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.679 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.416 ' OE1' ' HB2' ' A' ' 33' ' ' GLU . 4.7 tt0 -99.64 151.79 20.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.633 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -103.76 -14.3 16.12 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.14 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.416 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 13.0 mm-40 -87.71 140.93 29.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.129 -178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.494 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 23.5 t70 -78.66 117.83 68.83 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.746 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.695 ' HB2' ' HG3' ' A' ' 7' ' ' PRO . 5.7 Cg_exo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 123.568 2.845 . . . . 0.0 112.834 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.884 HD21 ' HG3' ' A' ' 12' ' ' LYS . 3.6 mm? . . . . . 0 C--O 1.232 0.147 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.772 ' HG3' ' HB2' ' A' ' 35' ' ' PRO . 3.1 Cg_endo -49.17 134.4 30.32 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.556 2.171 . . . . 0.0 110.457 176.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -42.66 98.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.716 2.944 . . . . 0.0 113.408 -171.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 24' ' ' ASN . . . 128.42 -24.51 4.96 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.117 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.631 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 97.3 m95 -91.11 165.27 13.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.799 0.333 . . . . 0.0 111.535 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.563 ' HB3' HG12 ' A' ' 23' ' ' VAL . 71.9 tt0 -162.19 151.0 15.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.625 175.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.884 ' HG3' HD21 ' A' ' 6' ' ' LEU . 34.0 mtmt -97.7 98.08 9.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.438 0.637 . . . . 0.0 109.334 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.411 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 9.9 mtm180 -105.48 160.28 15.27 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.483 -172.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.1 p -95.05 140.93 29.31 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.474 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HA ' ' HE2' ' A' ' 21' ' ' TYR . 30.5 t70 -93.4 175.54 6.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.036 -177.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.425 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 30.0 p -65.41 -33.84 76.9 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.63 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -92.13 13.12 19.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.537 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.44 -1.06 89.16 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.251 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -72.73 -174.72 1.49 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.942 0.401 . . . . 0.0 111.008 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.8 m -133.31 124.41 48.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.144 0.497 . . . . 0.0 110.521 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.444 ' HE2' ' HA ' ' A' ' 15' ' ' ASP . 41.5 p90 -119.15 167.07 12.17 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.63 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 79.0 m-85 -110.87 113.36 25.87 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 6.1 p -99.9 141.33 17.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.578 -173.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB3' ' H ' ' A' ' 29' ' ' ILE . 21.7 t-20 -112.35 117.32 32.13 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -80.23 -19.57 46.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.484 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -81.78 -63.5 1.38 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.546 -175.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.704 HG23 HG12 ' A' ' 29' ' ' ILE . 13.1 t -95.32 -2.37 49.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.2 0.524 . . . . 0.0 110.974 -176.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 23.6 mmt180 63.42 67.88 0.63 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.943 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.704 HG12 HG23 ' A' ' 27' ' ' THR . 38.1 mm -122.96 130.98 74.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.201 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.3 m -109.16 95.22 5.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.104 0.478 . . . . 0.0 110.219 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.418 ' HG3' HG22 ' A' ' 29' ' ' ILE . 18.1 mt-30 -102.13 172.8 6.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.309 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -120.84 6.18 10.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.964 0.412 . . . . 0.0 110.193 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -99.56 139.64 34.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.107 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 10.7 t0 -83.56 116.7 65.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.872 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.772 ' HB2' ' HG3' ' A' ' 7' ' ' PRO . 6.5 Cg_exo . . . . . 0 CA--C 1.532 0.404 0 C-N-CA 123.512 2.808 . . . . 0.0 114.295 -176.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.808 HD21 ' HG3' ' A' ' 12' ' ' LYS . 4.5 mm? . . . . . 0 CA--C 1.516 -0.347 0 CA-C-O 120.664 0.269 . . . . 0.0 110.75 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.546 ' HD2' ' HB2' ' A' ' 10' ' ' TRP . 16.6 Cg_exo -66.01 149.05 86.31 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.576 2.184 . . . . 0.0 109.983 175.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -54.78 100.61 0.07 OUTLIER 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.349 2.7 . . . . 0.0 113.312 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.503 ' HA3' ' ND2' ' A' ' 26' ' ' ASN . . . 124.56 -19.68 7.04 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.693 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.717 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 97.1 m95 -99.98 162.63 12.87 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.532 0.333 . . . . 0.0 110.769 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 9.6 tp10 -168.09 156.64 9.0 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.808 ' HG3' HD21 ' A' ' 6' ' ' LEU . 23.7 mtmm -95.81 88.23 4.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -92.78 152.64 19.35 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.816 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.1 p -94.32 131.32 40.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.67 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 16' ' ' SER . 24.1 t0 -86.03 -178.3 6.51 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.244 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.488 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 57.1 p -58.73 -50.5 73.66 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.039 -173.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -93.9 28.78 2.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.759 -172.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.13 -6.19 80.27 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.532 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.05 167.07 1.79 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.944 0.402 . . . . 0.0 111.33 174.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.9 m -129.08 137.67 56.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.419 ' CD1' HG23 ' A' ' 30' ' ' THR . 52.0 p90 -140.02 161.3 37.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.127 0.489 . . . . 0.0 110.298 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 85.3 m-85 -103.41 114.18 28.25 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.684 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.717 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 9.9 p -97.28 136.13 29.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.564 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 53.7 t-20 -114.45 97.88 6.57 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 171.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -76.77 -11.7 59.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.113 0.482 . . . . 0.0 111.479 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.503 ' ND2' ' HA3' ' A' ' 9' ' ' GLY . 72.6 m-20 -66.02 -62.71 1.34 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.838 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.0 p -96.06 2.35 53.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.665 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 64.57 40.75 5.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.008 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.1 mm -105.35 128.12 59.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.198 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.419 HG23 ' CD1' ' A' ' 21' ' ' TYR . 40.5 m -96.48 109.3 21.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.897 173.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -111.2 161.35 16.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.135 0.493 . . . . 0.0 110.239 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -116.76 -22.44 8.58 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.519 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -85.82 159.1 19.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.922 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 26.6 t70 -77.46 126.63 84.47 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.096 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.487 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 17.4 Cg_exo . . . . . 0 C--N 1.345 0.349 0 C-N-CA 123.772 2.981 . . . . 0.0 113.059 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.75 HD21 ' HG3' ' A' ' 12' ' ' LYS . 3.6 mm? . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.634 0.254 . . . . 0.0 110.334 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.731 ' HG2' ' CD1' ' A' ' 10' ' ' TRP . 14.5 Cg_endo -58.98 147.91 87.64 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.599 2.199 . . . . 0.0 110.789 170.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 7' ' ' PRO . 77.9 Cg_exo -50.14 100.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.526 2.817 . . . . 0.0 113.309 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 24' ' ' ASN . . . 125.91 -18.76 6.61 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.491 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.731 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 95.5 m95 -96.25 166.93 11.49 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -174.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -162.2 155.21 20.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.75 ' HG3' HD21 ' A' ' 6' ' ' LEU . 37.2 mtmt -98.95 70.65 1.84 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.434 ' HG2' ' OE1' ' A' ' 11' ' ' GLU . 14.4 mtm180 -83.54 159.06 21.75 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.901 -172.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.5 p -108.56 158.29 17.7 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.707 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -108.6 -174.25 2.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.179 0.514 . . . . 0.0 110.794 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.3 p -77.38 -4.67 46.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.71 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -94.41 -30.91 14.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.504 0.669 . . . . 0.0 109.694 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.02 15.84 8.88 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -96.75 164.72 12.45 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.274 -0.463 . . . . 0.0 110.759 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.19 132.79 62.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.118 0.485 . . . . 0.0 110.892 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.33 156.45 46.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.72 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.63 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 86.3 m-85 -97.81 121.81 40.17 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.81 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 4.8 p -106.77 136.34 42.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.188 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.556 ' HB3' ' H ' ' A' ' 29' ' ' ILE . 26.0 t-20 -108.79 121.66 45.53 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -82.1 -26.28 33.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.727 0.298 . . . . 0.0 111.302 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.27 -57.08 9.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.392 -174.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.741 HG23 HG12 ' A' ' 29' ' ' ILE . 3.7 t -119.0 11.55 12.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.168 0.508 . . . . 0.0 111.48 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 20.3 mmt180 60.96 63.42 1.27 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.942 175.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.741 HG12 HG23 ' A' ' 27' ' ' THR . 49.1 mm -111.71 121.16 63.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.312 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.7 m -102.08 102.19 12.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -119.54 142.51 48.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.392 0.615 . . . . 0.0 110.973 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -93.74 -24.15 17.93 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.877 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.1 147.87 34.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.33 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 9.8 t0 -76.35 121.0 84.1 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 34' ' ' ASP . 18.5 Cg_exo . . . . . 0 C--N 1.344 0.324 0 C-N-CA 123.022 2.481 . . . . 0.0 112.112 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.613 ' HG ' ' HA ' ' A' ' 11' ' ' GLU . 4.5 mm? . . . . . 0 C--O 1.235 0.316 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.821 ' HG3' ' HB2' ' A' ' 35' ' ' PRO . 12.0 Cg_endo -53.9 127.83 27.21 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 121.814 1.676 . . . . 0.0 110.567 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -34.4 98.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 124.576 3.518 . . . . 0.0 114.445 -169.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.67 -19.83 6.17 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.222 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.712 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 94.4 m95 -94.6 164.02 13.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.83 0.348 . . . . 0.0 111.53 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.613 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 9.7 tp10 -162.7 153.7 17.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.878 171.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.613 ' HG2' ' CE2' ' A' ' 22' ' ' PHE . 52.3 mtpt -93.33 95.15 9.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.423 0.63 . . . . 0.0 110.399 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 6.7 mtt180 -89.44 166.13 13.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.211 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.8 OUTLIER -120.63 143.44 48.68 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.958 176.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -94.94 -168.94 1.9 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.59 0.233 . . . . 0.0 110.736 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.8 p -67.72 -20.57 65.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.888 0.375 . . . . 0.0 111.588 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -89.7 -27.84 19.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.557 0.694 . . . . 0.0 109.614 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.54 12.58 18.87 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.355 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 14' ' ' THR . 8.2 mtt180 -85.11 153.58 22.6 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 15.7 m -97.95 123.96 50.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.417 0.627 . . . . 0.0 111.347 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -123.58 146.74 47.92 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.122 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.613 ' CE2' ' HG2' ' A' ' 12' ' ' LYS . 62.9 m-85 -95.61 117.44 30.46 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.098 0.475 . . . . 0.0 110.213 -173.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 7.1 p -103.61 131.57 51.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.803 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.665 ' HB3' ' H ' ' A' ' 29' ' ' ILE . 26.8 t-20 -103.56 116.53 32.54 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -79.19 -19.23 51.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.636 0.255 . . . . 0.0 110.985 -174.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -69.43 -62.84 1.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.294 -175.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.678 HG23 HG12 ' A' ' 29' ' ' ILE . 14.4 t -117.93 15.01 14.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.681 0.753 . . . . 0.0 111.121 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 11.4 mmt180 60.38 61.14 1.84 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.563 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.678 HG12 HG23 ' A' ' 27' ' ' THR . 49.5 mm -104.01 117.08 48.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.899 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.0 m -96.05 98.32 10.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -101.71 161.9 13.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.738 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -118.01 -7.58 10.84 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.527 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.73 148.09 34.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.923 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 33.2 t70 -68.2 121.82 81.71 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.096 -173.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.821 ' HB2' ' HG3' ' A' ' 7' ' ' PRO . 6.9 Cg_exo . . . . . 0 N--CA 1.463 -0.313 0 C-N-CA 123.585 2.856 . . . . 0.0 112.239 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.48 HD21 ' HG3' ' A' ' 12' ' ' LYS . 4.1 mm? . . . . . 0 N--CA 1.454 -0.249 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.626 ' HG2' ' CD1' ' A' ' 10' ' ' TRP . 18.3 Cg_endo -59.7 134.6 58.57 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.961 1.774 . . . . 0.0 110.339 174.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.69 110.75 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.518 2.812 . . . . 0.0 113.068 -176.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.86 -29.1 5.92 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.881 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.626 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 97.7 m95 -98.18 159.29 15.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.031 0.443 . . . . 0.0 112.109 -174.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -161.31 149.1 15.26 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.049 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.48 ' HG3' HD21 ' A' ' 6' ' ' LEU . 55.4 mtpt -94.87 105.68 17.62 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.846 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -120.39 152.13 38.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.907 -172.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 40.0 p -90.08 148.7 22.87 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.026 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -96.32 -166.44 1.42 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.683 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.2 p -68.29 -17.08 64.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.763 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -90.86 -42.36 10.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.95 18.84 2.82 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.234 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 14' ' ' THR . 15.5 mtt180 -95.37 149.76 21.02 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.2 m -96.22 109.14 22.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.653 0.739 . . . . 0.0 111.258 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -101.81 174.91 5.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.289 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.432 ' CE1' ' HG2' ' A' ' 12' ' ' LYS . 69.4 m-85 -112.5 109.31 18.81 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.369 0.604 . . . . 0.0 109.818 -177.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 8.2 p -94.76 137.96 21.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.33 -176.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 27.1 t-20 -105.91 115.01 29.5 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 172.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -75.94 -21.03 57.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.83 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -73.62 -65.63 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.92 0.39 . . . . 0.0 111.221 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.808 HG23 HG12 ' A' ' 29' ' ' ILE . 6.4 t -102.03 4.55 39.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.263 0.554 . . . . 0.0 111.262 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 19.2 mmt180 59.21 63.78 1.52 Allowed 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.95 178.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.808 HG12 HG23 ' A' ' 27' ' ' THR . 45.5 mm -113.33 127.28 70.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.889 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -101.45 100.37 10.81 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.611 ' HG3' HG22 ' A' ' 29' ' ' ILE . 17.7 mt-30 -111.59 155.24 23.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.961 0.41 . . . . 0.0 110.89 -177.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -103.23 -9.62 19.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.684 0.754 . . . . 0.0 109.174 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -80.38 148.18 30.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.889 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.502 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 9.1 t70 -80.74 122.92 82.67 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.461 -176.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 34' ' ' ASP . 5.6 Cg_exo . . . . . 0 C--N 1.344 0.332 0 C-N-CA 123.645 2.897 . . . . 0.0 113.599 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.45 70.05 0.69 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.261 0.553 . . . . 0.0 110.683 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -80.01 21.9 0.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.318 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.5 163.94 18.87 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.021 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.45 168.35 24.98 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.233 2.622 . . . . 0.0 111.474 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.848 HD21 ' HG3' ' A' ' 12' ' ' LYS . 4.2 mm? -73.95 138.94 76.22 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.331 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.921 ' HD3' ' HD3' ' A' ' 36' ' ' ARG . 5.9 Cg_exo -53.49 142.22 59.83 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.916 2.411 . . . . 0.0 110.809 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -40.91 97.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.041 3.161 . . . . 0.0 114.261 -172.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.61 -27.34 4.97 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.345 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.608 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 95.7 m95 -85.55 163.49 18.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.472 0.177 . . . . 0.0 111.447 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.586 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 10.1 tp10 -163.61 152.18 13.76 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.096 173.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.848 ' HG3' HD21 ' A' ' 6' ' ' LEU . 30.0 mtmt -91.79 100.92 13.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.355 0.598 . . . . 0.0 109.594 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -111.22 163.68 13.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.146 -173.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.3 p -114.39 147.73 38.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.124 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -94.94 -169.38 1.99 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.622 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.4 p -71.31 -24.87 62.21 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.409 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.91 -25.8 14.88 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.045 -171.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.42 14.79 2.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.054 -1.069 . . . . 0.0 113.003 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -87.28 153.73 21.25 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.862 -0.199 . . . . 0.0 110.483 177.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.8 m -104.22 121.98 56.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.19 0.519 . . . . 0.0 110.169 174.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.457 ' CD1' HG23 ' A' ' 30' ' ' THR . 43.2 p90 -124.69 171.64 9.91 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.806 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.531 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 80.2 m-85 -117.23 118.16 31.55 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.779 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 9.8 p -96.83 131.73 42.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.652 -175.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -101.1 115.86 31.47 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -66.95 -32.73 74.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.82 -178.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -66.46 -61.2 2.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.652 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.544 ' HB ' HG12 ' A' ' 29' ' ' ILE . 11.2 p -87.28 -13.87 42.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.767 -176.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.422 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 16.5 mmt180 66.13 33.29 7.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.423 -176.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.544 HG12 ' HB ' ' A' ' 27' ' ' THR . 41.8 mm -94.47 134.58 31.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.879 -176.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.457 HG23 ' CD1' ' A' ' 21' ' ' TYR . 69.6 m -98.11 96.25 7.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.011 175.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -101.56 158.69 15.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.988 0.423 . . . . 0.0 110.031 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -111.99 -29.29 7.69 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.126 -174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.82 140.02 56.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.05 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.489 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 8.9 t0 -80.01 120.69 80.59 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.755 -176.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 34' ' ' ASP . 4.4 Cg_exo -76.62 -21.71 12.69 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.35 2.7 . . . . 0.0 112.376 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.921 ' HD3' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -91.81 42.68 1.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.359 0.6 . . . . 0.0 110.978 -178.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 C--O 1.247 0.966 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.896 -179.431 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.83 124.37 48.22 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.9 mtp -101.33 137.47 39.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.109 0.48 . . . . 0.0 111.454 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.0 -130.84 7.97 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.364 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.18 -157.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 124.168 3.245 . . . . 0.0 112.471 173.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.59 HD21 ' HG3' ' A' ' 12' ' ' LYS . 4.6 mm? -56.72 164.27 2.26 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.621 172.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.629 ' HG2' ' HB2' ' A' ' 35' ' ' PRO . 11.6 Cg_exo -62.4 151.09 84.82 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.861 1.707 . . . . 0.0 109.82 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -39.68 98.28 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.801 3.001 . . . . 0.0 114.473 -174.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.96 -16.75 27.77 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.447 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.587 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 95.1 m95 -87.46 168.48 13.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.141 0.496 . . . . 0.0 112.28 -174.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.544 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 65.1 tt0 -162.07 151.86 16.41 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.433 175.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.59 ' HG3' HD21 ' A' ' 6' ' ' LEU . 53.8 mtpt -95.36 100.73 12.46 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -106.56 161.04 14.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.821 -172.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 p -104.47 138.39 40.92 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.763 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 16' ' ' SER . 17.3 t70 -97.29 -176.5 3.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.288 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.486 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 35.5 p -57.66 -56.98 14.88 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.515 0.726 . . . . 0.0 112.57 -173.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -84.24 20.28 1.66 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.783 0.325 . . . . 0.0 111.649 -174.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.4 9.43 81.75 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.703 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -65.83 161.88 20.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.2 m -124.89 132.24 71.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 120.938 0.399 . . . . 0.0 110.099 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -139.93 174.16 10.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.008 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.563 ' CE2' ' HG2' ' A' ' 12' ' ' LYS . 58.9 m-85 -115.78 121.99 44.1 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.892 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 3.1 p -110.45 142.73 22.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.679 -175.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -106.07 111.79 24.56 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 11' ' ' GLU . 27.9 m80 -65.07 -36.53 84.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.284 -173.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -62.13 -62.59 1.66 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.936 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.823 HG23 HG12 ' A' ' 29' ' ' ILE . 5.3 t -104.26 8.14 36.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.08 0.467 . . . . 0.0 111.677 -176.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 60.04 45.57 11.84 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.435 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.823 HG12 HG23 ' A' ' 27' ' ' THR . 44.0 mm -96.68 134.31 34.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.186 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.6 m -108.35 122.79 47.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.663 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -127.13 154.15 45.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.426 0.632 . . . . 0.0 110.556 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -99.61 -34.3 10.27 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.412 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -88.18 152.17 22.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.883 0.373 . . . . 0.0 111.4 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -70.71 121.77 84.73 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.018 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.629 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 17.3 Cg_exo -70.92 -18.33 31.64 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.563 2.842 . . . . 0.0 113.447 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -93.19 66.68 4.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.39 0.614 . . . . 0.0 112.05 -173.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.248 1.023 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.633 174.674 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 3' ' ' MET . . . -80.33 102.58 9.65 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 61.7 mtt 67.04 -84.6 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 123.726 0.641 . . . . 0.0 110.776 -173.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.14 106.09 3.08 Favored Glycine 0 C--N 1.303 -1.26 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.671 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -53.02 144.58 45.29 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.579 2.853 . . . . 0.0 112.888 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.678 ' HG ' ' HA ' ' A' ' 11' ' ' GLU . 3.1 mm? -82.34 160.04 63.24 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.117 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.695 ' HG3' ' HB2' ' A' ' 35' ' ' PRO . 6.0 Cg_endo -54.02 143.95 59.48 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.26 1.974 . . . . 0.0 110.82 172.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 7' ' ' PRO . 71.9 Cg_exo -49.45 106.54 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.405 2.737 . . . . 0.0 112.874 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.9 -21.19 9.04 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.109 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.622 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 97.6 m95 -98.7 166.22 11.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.695 0.284 . . . . 0.0 111.35 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.678 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 10.0 tp10 -167.7 155.14 8.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.181 169.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.585 ' HG3' HD21 ' A' ' 6' ' ' LEU . 38.2 mtpt -93.33 95.06 9.09 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.419 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.582 ' HD3' HG11 ' A' ' 23' ' ' VAL . 3.5 mpt_? -98.56 -175.6 3.13 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.472 174.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 16.5 p -129.66 131.31 46.36 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.76 -171.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.428 ' OD1' ' HD2' ' A' ' 21' ' ' TYR . 1.1 m-20 -79.65 178.19 8.34 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.108 0.48 . . . . 0.0 109.709 173.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.0 p -74.63 -3.27 30.22 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.764 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.413 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 10.9 p30 -102.06 -1.16 32.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.989 0.423 . . . . 0.0 110.485 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.72 -3.17 67.71 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.068 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 14' ' ' THR . 2.6 mtt180 -68.69 160.71 29.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.906 0.384 . . . . 0.0 111.149 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 12.1 m -120.08 108.26 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.607 174.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.428 ' HD2' ' OD1' ' A' ' 15' ' ' ASP . 25.2 p90 -104.18 157.47 17.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.227 0.537 . . . . 0.0 110.964 -176.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.464 ' CE2' ' HG2' ' A' ' 12' ' ' LYS . 49.6 m-85 -101.97 110.81 22.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.474 -177.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.582 HG11 ' HD3' ' A' ' 13' ' ' ARG . 7.6 p -105.56 124.22 60.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.717 -173.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -93.33 120.14 33.28 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -77.19 -20.88 54.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.517 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -76.15 -50.71 13.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.161 0.505 . . . . 0.0 110.724 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.6 p -104.87 -3.13 23.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.334 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.52 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 4.5 mpt_? 60.58 40.1 17.15 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.785 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.0 mm -96.94 118.04 42.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.477 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -93.74 95.15 8.97 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.679 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.416 ' OE1' ' HB2' ' A' ' 33' ' ' GLU . 4.7 tt0 -99.64 151.79 20.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.633 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -103.76 -14.3 16.12 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.14 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.416 ' HB2' ' OE1' ' A' ' 31' ' ' GLN . 13.0 mm-40 -87.71 140.93 29.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.129 -178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.494 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 23.5 t70 -78.66 117.83 68.83 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.746 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.695 ' HB2' ' HG3' ' A' ' 7' ' ' PRO . 5.7 Cg_exo -81.44 -11.29 11.86 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.568 2.845 . . . . 0.0 112.834 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -81.97 48.29 1.21 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.979 -172.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.252 1.207 0 CA-C-O 119.067 -0.492 . . . . 0.0 110.534 179.453 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.65 12.96 19.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.287 0.565 . . . . 0.0 110.908 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.8 mtp -102.0 150.13 23.54 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.797 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.28 138.96 6.05 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.344 -0.931 . . . . 0.0 112.28 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -45.75 150.7 1.51 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 124.134 3.223 . . . . 0.0 112.996 172.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.884 HD21 ' HG3' ' A' ' 12' ' ' LYS . 3.6 mm? -67.26 149.46 98.42 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.447 176.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.772 ' HG3' ' HB2' ' A' ' 35' ' ' PRO . 3.1 Cg_endo -49.17 134.4 30.32 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.556 2.171 . . . . 0.0 110.457 176.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -42.66 98.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.716 2.944 . . . . 0.0 113.408 -171.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 24' ' ' ASN . . . 128.42 -24.51 4.96 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.117 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.631 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 97.3 m95 -91.11 165.27 13.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.799 0.333 . . . . 0.0 111.535 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.563 ' HB3' HG12 ' A' ' 23' ' ' VAL . 71.9 tt0 -162.19 151.0 15.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.625 175.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.884 ' HG3' HD21 ' A' ' 6' ' ' LEU . 34.0 mtmt -97.7 98.08 9.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.438 0.637 . . . . 0.0 109.334 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.411 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . 9.9 mtm180 -105.48 160.28 15.27 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.483 -172.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.1 p -95.05 140.93 29.31 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.474 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HA ' ' HE2' ' A' ' 21' ' ' TYR . 30.5 t70 -93.4 175.54 6.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.036 -177.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.425 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 30.0 p -65.41 -33.84 76.9 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.63 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -92.13 13.12 19.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.537 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.44 -1.06 89.16 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.251 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -72.73 -174.72 1.49 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.942 0.401 . . . . 0.0 111.008 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.8 m -133.31 124.41 48.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.144 0.497 . . . . 0.0 110.521 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.444 ' HE2' ' HA ' ' A' ' 15' ' ' ASP . 41.5 p90 -119.15 167.07 12.17 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.63 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 79.0 m-85 -110.87 113.36 25.87 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 6.1 p -99.9 141.33 17.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.578 -173.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB3' ' H ' ' A' ' 29' ' ' ILE . 21.7 t-20 -112.35 117.32 32.13 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -80.23 -19.57 46.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.484 -174.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -81.78 -63.5 1.38 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.546 -175.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.704 HG23 HG12 ' A' ' 29' ' ' ILE . 13.1 t -95.32 -2.37 49.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.2 0.524 . . . . 0.0 110.974 -176.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 23.6 mmt180 63.42 67.88 0.63 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.943 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.704 HG12 HG23 ' A' ' 27' ' ' THR . 38.1 mm -122.96 130.98 74.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.201 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.3 m -109.16 95.22 5.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.104 0.478 . . . . 0.0 110.219 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.418 ' HG3' HG22 ' A' ' 29' ' ' ILE . 18.1 mt-30 -102.13 172.8 6.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.309 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -120.84 6.18 10.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.964 0.412 . . . . 0.0 110.193 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -99.56 139.64 34.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.107 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 10.7 t0 -83.56 116.7 65.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.872 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.772 ' HB2' ' HG3' ' A' ' 7' ' ' PRO . 6.5 Cg_exo -78.54 -11.86 15.5 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.512 2.808 . . . . 0.0 114.295 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.649 ' HD3' HD13 ' A' ' 6' ' ' LEU . 42.6 mtm180 -81.99 53.71 2.28 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -168.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 C--O 1.253 1.263 0 CA-C-O 118.14 -0.933 . . . . 0.0 110.119 174.839 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 112.239 -0.344 . . . . 0.0 112.239 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.52 38.49 29.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.015 0.436 . . . . 0.0 111.271 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.5 mtt -147.59 151.68 36.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.544 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.2 -76.27 1.18 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 172.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -78.97 178.21 7.81 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.238 2.625 . . . . 0.0 111.799 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.808 HD21 ' HG3' ' A' ' 12' ' ' LYS . 4.5 mm? -78.84 166.77 40.09 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.75 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.546 ' HD2' ' HB2' ' A' ' 10' ' ' TRP . 16.6 Cg_exo -66.01 149.05 86.31 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.576 2.184 . . . . 0.0 109.983 175.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -54.78 100.61 0.07 OUTLIER 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.349 2.7 . . . . 0.0 113.312 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.503 ' HA3' ' ND2' ' A' ' 26' ' ' ASN . . . 124.56 -19.68 7.04 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.693 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.717 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 97.1 m95 -99.98 162.63 12.87 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.532 0.333 . . . . 0.0 110.769 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 9.6 tp10 -168.09 156.64 9.0 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.808 ' HG3' HD21 ' A' ' 6' ' ' LEU . 23.7 mtmm -95.81 88.23 4.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -92.78 152.64 19.35 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.816 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.1 p -94.32 131.32 40.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.67 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 16' ' ' SER . 24.1 t0 -86.03 -178.3 6.51 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.244 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.488 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 57.1 p -58.73 -50.5 73.66 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.039 -173.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -93.9 28.78 2.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.759 -172.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.13 -6.19 80.27 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.532 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.05 167.07 1.79 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.944 0.402 . . . . 0.0 111.33 174.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.9 m -129.08 137.67 56.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.419 ' CD1' HG23 ' A' ' 30' ' ' THR . 52.0 p90 -140.02 161.3 37.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.127 0.489 . . . . 0.0 110.298 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 85.3 m-85 -103.41 114.18 28.25 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.684 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.717 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 9.9 p -97.28 136.13 29.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.564 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 53.7 t-20 -114.45 97.88 6.57 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 171.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -76.77 -11.7 59.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.113 0.482 . . . . 0.0 111.479 -174.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.503 ' ND2' ' HA3' ' A' ' 9' ' ' GLY . 72.6 m-20 -66.02 -62.71 1.34 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.838 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.0 p -96.06 2.35 53.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.665 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 64.57 40.75 5.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.008 176.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.1 mm -105.35 128.12 59.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.198 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.419 HG23 ' CD1' ' A' ' 21' ' ' TYR . 40.5 m -96.48 109.3 21.89 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.897 173.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -111.2 161.35 16.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.135 0.493 . . . . 0.0 110.239 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -116.76 -22.44 8.58 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.519 -178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -85.82 159.1 19.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.922 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 26.6 t70 -77.46 126.63 84.47 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.096 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.487 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 17.4 Cg_exo -70.38 -27.22 23.76 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.772 2.981 . . . . 0.0 113.059 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.554 HH21 HD22 ' A' ' 6' ' ' LEU . 11.0 mtt85 -79.77 -15.73 56.91 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.684 0.278 . . . . 0.0 110.709 -176.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.5 p . . . . . 0 C--O 1.249 1.046 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.072 177.898 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 112.246 -0.342 . . . . 0.0 112.246 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.18 88.83 6.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.185 0.517 . . . . 0.0 110.018 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.3 mtt -91.05 17.27 8.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.147 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.97 136.85 46.06 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.832 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.35 171.0 18.88 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.066 2.511 . . . . 0.0 112.092 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.75 HD21 ' HG3' ' A' ' 12' ' ' LYS . 3.6 mm? -100.46 155.5 36.31 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.334 177.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.731 ' HG2' ' CD1' ' A' ' 10' ' ' TRP . 14.5 Cg_endo -58.98 147.91 87.64 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.599 2.199 . . . . 0.0 110.789 170.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 7' ' ' PRO . 77.9 Cg_exo -50.14 100.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.526 2.817 . . . . 0.0 113.309 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 24' ' ' ASN . . . 125.91 -18.76 6.61 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.491 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.731 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 95.5 m95 -96.25 166.93 11.49 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -174.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -162.2 155.21 20.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.75 ' HG3' HD21 ' A' ' 6' ' ' LEU . 37.2 mtmt -98.95 70.65 1.84 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.434 ' HG2' ' OE1' ' A' ' 11' ' ' GLU . 14.4 mtm180 -83.54 159.06 21.75 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.901 -172.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.5 p -108.56 158.29 17.7 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.707 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -108.6 -174.25 2.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.179 0.514 . . . . 0.0 110.794 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.3 p -77.38 -4.67 46.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.71 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -94.41 -30.91 14.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.504 0.669 . . . . 0.0 109.694 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.02 15.84 8.88 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -96.75 164.72 12.45 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.274 -0.463 . . . . 0.0 110.759 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.19 132.79 62.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.118 0.485 . . . . 0.0 110.892 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -140.33 156.45 46.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.72 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.63 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 86.3 m-85 -97.81 121.81 40.17 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.81 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 4.8 p -106.77 136.34 42.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.188 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.556 ' HB3' ' H ' ' A' ' 29' ' ' ILE . 26.0 t-20 -108.79 121.66 45.53 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -82.1 -26.28 33.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.727 0.298 . . . . 0.0 111.302 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.27 -57.08 9.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.392 -174.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.741 HG23 HG12 ' A' ' 29' ' ' ILE . 3.7 t -119.0 11.55 12.51 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.168 0.508 . . . . 0.0 111.48 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 20.3 mmt180 60.96 63.42 1.27 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.942 175.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.741 HG12 HG23 ' A' ' 27' ' ' THR . 49.1 mm -111.71 121.16 63.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.312 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.7 m -102.08 102.19 12.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -119.54 142.51 48.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.392 0.615 . . . . 0.0 110.973 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -93.74 -24.15 17.93 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.877 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.1 147.87 34.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.33 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 9.8 t0 -76.35 121.0 84.1 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 34' ' ' ASP . 18.5 Cg_exo -65.87 -22.7 55.9 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.022 2.481 . . . . 0.0 112.112 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.683 ' HD3' HD13 ' A' ' 6' ' ' LEU . 47.4 mtm180 -96.43 -5.42 39.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.349 -170.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--O 1.244 0.768 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.056 -179.966 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.17 19.23 10.76 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.107 0.563 . . . . 0.0 112.124 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.8 mtp -88.22 89.26 7.92 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.18 145.11 9.25 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.456 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -80.12 131.08 8.62 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.527 2.151 . . . . 0.0 112.768 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.613 ' HG ' ' HA ' ' A' ' 11' ' ' GLU . 4.5 mm? -64.39 150.49 93.06 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 168.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.821 ' HG3' ' HB2' ' A' ' 35' ' ' PRO . 12.0 Cg_endo -53.9 127.83 27.21 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 121.814 1.676 . . . . 0.0 110.567 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -34.4 98.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 124.576 3.518 . . . . 0.0 114.445 -169.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.67 -19.83 6.17 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.222 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.712 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 94.4 m95 -94.6 164.02 13.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.83 0.348 . . . . 0.0 111.53 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.613 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 9.7 tp10 -162.7 153.7 17.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.878 171.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.613 ' HG2' ' CE2' ' A' ' 22' ' ' PHE . 52.3 mtpt -93.33 95.15 9.14 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.423 0.63 . . . . 0.0 110.399 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 6.7 mtt180 -89.44 166.13 13.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.211 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.8 OUTLIER -120.63 143.44 48.68 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.958 176.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -94.94 -168.94 1.9 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.59 0.233 . . . . 0.0 110.736 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.8 p -67.72 -20.57 65.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.888 0.375 . . . . 0.0 111.588 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -89.7 -27.84 19.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.557 0.694 . . . . 0.0 109.614 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.54 12.58 18.87 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.355 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 14' ' ' THR . 8.2 mtt180 -85.11 153.58 22.6 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 13' ' ' ARG . 15.7 m -97.95 123.96 50.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.417 0.627 . . . . 0.0 111.347 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -123.58 146.74 47.92 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.122 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.613 ' CE2' ' HG2' ' A' ' 12' ' ' LYS . 62.9 m-85 -95.61 117.44 30.46 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.098 0.475 . . . . 0.0 110.213 -173.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 7.1 p -103.61 131.57 51.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.803 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.665 ' HB3' ' H ' ' A' ' 29' ' ' ILE . 26.8 t-20 -103.56 116.53 32.54 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -79.19 -19.23 51.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.636 0.255 . . . . 0.0 110.985 -174.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -69.43 -62.84 1.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.294 -175.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.678 HG23 HG12 ' A' ' 29' ' ' ILE . 14.4 t -117.93 15.01 14.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.681 0.753 . . . . 0.0 111.121 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 11.4 mmt180 60.38 61.14 1.84 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.563 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.678 HG12 HG23 ' A' ' 27' ' ' THR . 49.5 mm -104.01 117.08 48.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.899 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.0 m -96.05 98.32 10.27 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -101.71 161.9 13.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.738 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -118.01 -7.58 10.84 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.527 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.73 148.09 34.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.923 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 33.2 t70 -68.2 121.82 81.71 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.096 -173.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.821 ' HB2' ' HG3' ' A' ' 7' ' ' PRO . 6.9 Cg_exo -77.27 -17.73 14.65 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.585 2.856 . . . . 0.0 112.239 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.534 ' HG3' ' HD3' ' A' ' 7' ' ' PRO . 8.8 mtp180 -68.09 -73.18 0.15 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.461 -173.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.845 -175.089 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.78 130.63 2.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.329 . . . . 0.0 110.698 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.8 mtm -69.8 143.04 53.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.021 175.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.53 124.49 0.73 Allowed Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.656 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -51.86 134.58 48.62 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.635 2.89 . . . . 0.0 112.568 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.48 HD21 ' HG3' ' A' ' 12' ' ' LYS . 4.1 mm? -68.42 156.91 89.4 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.77 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.626 ' HG2' ' CD1' ' A' ' 10' ' ' TRP . 18.3 Cg_endo -59.7 134.6 58.57 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.961 1.774 . . . . 0.0 110.339 174.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.69 110.75 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.518 2.812 . . . . 0.0 113.068 -176.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.86 -29.1 5.92 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.881 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.626 ' CD1' ' HG2' ' A' ' 7' ' ' PRO . 97.7 m95 -98.18 159.29 15.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.031 0.443 . . . . 0.0 112.109 -174.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -161.31 149.1 15.26 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.049 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.48 ' HG3' HD21 ' A' ' 6' ' ' LEU . 55.4 mtpt -94.87 105.68 17.62 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.846 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -120.39 152.13 38.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.907 -172.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 40.0 p -90.08 148.7 22.87 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.026 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -96.32 -166.44 1.42 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.683 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.2 p -68.29 -17.08 64.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.763 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -90.86 -42.36 10.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.95 18.84 2.82 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.234 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 14' ' ' THR . 15.5 mtt180 -95.37 149.76 21.02 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.2 m -96.22 109.14 22.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.653 0.739 . . . . 0.0 111.258 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -101.81 174.91 5.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.289 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.432 ' CE1' ' HG2' ' A' ' 12' ' ' LYS . 69.4 m-85 -112.5 109.31 18.81 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.369 0.604 . . . . 0.0 109.818 -177.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 10' ' ' TRP . 8.2 p -94.76 137.96 21.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.33 -176.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 27.1 t-20 -105.91 115.01 29.5 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 172.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -75.94 -21.03 57.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.83 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -73.62 -65.63 0.8 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.92 0.39 . . . . 0.0 111.221 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.808 HG23 HG12 ' A' ' 29' ' ' ILE . 6.4 t -102.03 4.55 39.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.263 0.554 . . . . 0.0 111.262 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 19.2 mmt180 59.21 63.78 1.52 Allowed 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.95 178.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.808 HG12 HG23 ' A' ' 27' ' ' THR . 45.5 mm -113.33 127.28 70.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.889 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -101.45 100.37 10.81 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.611 ' HG3' HG22 ' A' ' 29' ' ' ILE . 17.7 mt-30 -111.59 155.24 23.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.961 0.41 . . . . 0.0 110.89 -177.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -103.23 -9.62 19.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.684 0.754 . . . . 0.0 109.174 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -80.38 148.18 30.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.889 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.502 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 9.1 t70 -80.74 122.92 82.67 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.461 -176.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 34' ' ' ASP . 5.6 Cg_exo -84.54 -8.7 9.42 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.645 2.897 . . . . 0.0 113.599 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.503 ' HG3' ' HD3' ' A' ' 7' ' ' PRO . 34.9 mtp85 -88.14 51.97 2.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.336 0.589 . . . . 0.0 111.886 -174.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.328 177.315 . . . . . . . . 0 0 . 1 stop_ save_